日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology  18(2)

日本癌治療学会

国立国会図書館雑誌記事索引 1 (1) 1966.03~;本タイトル等は最新号による;刊行頻度の変更あり;並列タイトル変遷: The journal of Japan Society for Cancer Therapy (1巻1号-32巻5号)→ The journal of Japan Society of Clinical Oncology (36巻1号-);46巻1号から46巻3号には「日本癌治療学会学術集会」49回の表示もあり;34巻から41巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」として2分冊刊行. 42巻から46巻まで各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会抄録号」, 各巻3号は「日本癌治療学会学術集会educational book」として3分冊刊行. 47巻以降各巻1号は「日本癌治療学会学術集会プログラム号」, 各巻2号は「日本癌治療学会学術集会educational book」として2分冊刊行;1巻1号 (Mar. 1, 1966)-;47巻3号は「JSCO」[電子資料] (USBメモリ) 50回として刊行, 48巻3号, 49巻3号は 「日本癌治療学会学術集会抄録号」 [電子資料] (USBメモリ) 51回, 52回として刊行

「国立国会図書館デジタルコレクション(雑誌)」より

[目次]

  • Presidential Lecture Review of Diagnosis and Treatment in Cancer of the Uterus / K.Masubuchi / p235~235
  • Special Lecture 1.Lung Cancer / Y.Hayata / p236~236
  • Special Lecture 2.Hepatitis and Hepatocellular Carcinoma / F.Ichida / p237~237
  • Special Lecture 3.Natural History of Human Cancer / H.Sugano / p238~238
  • Special Lecture 4.Not Received / /
  • Special Lecture 5.Current Clinical Results of New Drugs / M.Ogawa / p239~239
  • Round Table Discussion Cancer Therapy--The Present State and Future On Hematopoietic Tumors / S.Hibino / p240~240
  • Round Table Discussion Not Received Cancer Therapy in Gynecology Today and Tomorrow / T.Kato / p240~240
  • Round Table Discussion Cancer Surgery for Digestives Organs / T.Kajitani / p241~241
  • Round Table Discussion Present and Future of Radiation Oncology / Y.Shigematsu / p241~241
  • Round Table Discussion Problems Concerning Cancer Chemotherapy in Japan / H.Niitani / p242~242
  • Round Table Discussion The Approach to Cancer Therapy through Biomedical Engineering / K.Atsumi / p242~242
  • Round Table Discussion Sphincter Saving Surgical Treatment of Colorectal Cancer--Present and Future State / T.Muto / p243~243
  • Symposium1 Endeavors to Detect Early Cancer / / p244~252
  • 1.The Outcome and Future of Mass Population Screening for Uterine Cervical Cancer / K.Noda / p244~244
  • 2.New Approach to Diagnosis of Minute and Small Thyroid Cancer / N.Kasai / p245~245
  • 3.Early Detection of Lung Cancer / T.Naruke / p246~246
  • 4.Comparison of X-Ray and Endoscopy in the Detection of Cancer and Polyp of the Large Bowe1--Analysis by Office Computer / M.Maruyama / p247~247
  • 5.Early Diagnosis of Pancreatic Carcinoma / J.Ariyama / p248~248
  • 6.Early Diagnosis of Ovarian Malignances / M.Yakushiji / p249~249
  • 7.An Effort to Detect Carcinoma of the Corpus Uteri at an Early Stage / A.Yajima / p250~250
  • 8.Mass Screening Program for Prostatic Diseases / H.Watanabe / p251~251
  • 9.Detection of Esophageal and Gastric Cancer Problems Awaiting to be Solved and Efforts to Raise the Detectability / H.Shirakabe / p252~252
  • Symposium2 Therapeutic Problems of Lung Metastasis--The Organ Peculiarity / / p253~260
  • 1.Chemotherapy for Lung Metastasis of Cancer / K.Ota / p253~253
  • 2.Clinical Features and Management of Pulmonary Metastasis of the Breast Cancer / N.Horikoshi / p254~254
  • 3.Pulmonary Metastasis of Osteosarcoma / A.Tateishi et al. / p255~255
  • 4.Pulmonary Metastasis of Choriocarcinoma / Y.Tomoda et al. / p256~256
  • 5.Pulmonary Metastasis of Renal Cell Carcinoma / Y.Satomi / p257~257
  • 6.Metastatic Pulmonary Carcinoma--Organ Specificity and Treatment(Indications and Limitations of Surgical Treatment) / I.Kinoshita / p258~258
  • 7.Radiation Therapy of Pulmonary Metastases / T.Sugawara et al. / p259~259
  • 8.The Surgical Treatment for the Pulmonary Metastasis / N.Miyazawa / p260~260
  • Symposium3 Cancer Therapy with Interferon / / p261~266
  • 1.Introduction / Y.Sakurai / p261~261
  • 2.Preclinical Study of Antitumor Activity of Interferon / T.Kataoka / p262~262
  • 3.Direct Cytotoxic ActiVity of Human lnterferons:Its in vitro and in vivo Analysis / M.Shimoyama et al. / p263~263
  • 4.Clinical and Immunologial Studies of Human Fibroblast Interferon and Human Lymphoblastoid Interferon in Malignant Diseases / K.Ezaki / p264~264
  • 5.Clinical Effect and Pathological Observation in the Treatment of Malignant Melanoma with Intralesional Injection of HuIFN-β / K.Ishihara / p265~265
  • 6.Present State of Interferon Therapy for Malignant Brain Tumors / M.Nagai et al. / p266~266
  • 7.Not Received / /
  • Symposium4 Therapy for Recurrent Cancer / / p267~273
  • 1.Treatment of Recurrent Cancer / H.Furue / p267~267
  • 2.Treatment of Recurrent Gastrointestinal Cancer / T.Taguchi / p268~268
  • 3.Analysis on Recurrence of Lung Cancer and Its Treatment / Y.Yamaguchi / p269~269
  • 4.Significance of Salvage Operation for the Recurrent Head and Neck Carcinoma / C.Taketa / p270~270
  • 5.Treatment of Recurrent Cervical Cancer of the Uterus / H.Takamizawa / p271~271
  • 6.Treatment of Pain Caused by Metastases of Reactivated Prostatic Cancer with Ifosfamide / T.Kawai / p272~272
  • 7.Treatment of Relapsing Acute Leukemia / K.Yamada et al. / p273~273
  • Symposium5 Breast Cancer and Hormone Receptor / / p274~279
  • 1.Factors Affecting Estrogen and Progesterone Receptors in Primary Breast Cancer / K.Kuno / p274~274
  • 2.Clinical Significance of Estrogen Receptor in Breast Cancer Determined by Histochemical and Biochemical Assays / T.Tominaga / p275~275
  • 3.Biological and Clinical Evaluation of Breast Cancer from the Point of View of Hormone Receptor / M.Akagi et al. / p276~276
  • 4.ER and PgR: Clinical Significance and Some Problems in the Treatment of Breast Cancer / M.Izuo / p277~277
  • 5.Chemo-endocrine Therapy for Patients with Advanced Breast Cancer / K.Abe et al. / p278~278
  • 6.Changing Status of Estrogen Receptors in Breast Cancer and Treatments / Y.Nomura / p279~279
  • 7.Not Received / /
  • Symposium6 Detection of Pancreatic Cancer in Early Stage / / p280~284
  • 1.The Appraisal of E.R.C.P. / K.Yamao et al. / p280~280
  • 2.Early Detection of Pancreatic Cancer--From Stand Point of Screening / K.Ohhashi / p281~281
  • 3.Carcinoembryonic Antigen,Serum Amylase and Pancreozymin-secretin Test in Relation to Stages of Pancreatic Carcinoma / T.Kozu et al. / p282~282
  • 4.Not Received / /
  • 5.Role of Angiography in the Diagnosis of Small Resectable Pancreatic Carcinoma / S.Shimaguchi et al. / p283~283
  • 6.Early Detection of Pancreatic Cancer--From Standpoint of Prognosis / K.Takagi / p284~284
  • 7.Not Received / /
  • Symposium7 Some Problems in Old Aged Cancer Patients / / p285~291
  • 1.Introduction--Problems Involved in Cancer of the Elderly / K.Oota / p285~285
  • 2.Development, Growth and Spreading of Cancer and Ageing / M.Kanisawa / p286~286
  • 3.Not Received / /
  • 4.Surgical Treatment of Lung Cancer in Patients over the Age of 70 Years / K.Suemasu / p287~287
  • 5.The Problems on Cancer Patients in Old Age From the Viewpoint of Gastroenterological Surgery / M.Nishi et al. / p288~288
  • 6.Urinary Bladder Cancer in the Elderly Patient / M.Yokokawa et al, / p289~289
  • 7.Treatment of Cervical Cancer in the Aged / K.Sekiba / p290~290
  • 8.From the View Point of Radiotherapy / K.Kaneta / p291~291
  • Symposium8 Tumor Marker / / p292~298
  • 1.Present Status of Tumor Marker / N.Hattori / p292~292
  • 2.Syngeneic Mouse Monoclonal Antibodies against Melanoma Specific Antigens Shared in Various Mammalian Melanoma Cells / M.Taniguchi et al. / p293~293
  • 3.Tumor Markers Studied by New Anti-carbohydrate Antibodies and Solid-phase Enzyme Lectin Assay / T.Muramatsu / p294~294
  • 4.Not Received / /
  • 5.Tumor Markers in Hepatocellular Carcinoma (HCC) / N.Sawabu / p295~295
  • 6.Tumor Markers in Gynecologic Malignancies / S.Tojo et al. / p296~296
  • 7.Tumor Marker in Urology / J.Shimazaki / p297~297
  • 8.Hormone as Tumor Marker / K.Abe / p298~298
  • Symposium9 Cancer Diagnosis by Image Analysis / / p299~303
  • 1.Not Received / /
  • 2.Not Received / /
  • 3.A General View of Modern Ultrasound Diagnosis for Carcinoma of the Liver, Biliary Tract and Pancreas / M.Ohto / p299~299
  • 4.Staging of Bladder Cancer by Ultrasonography / T.Niijima / p300~300
  • 5.In vivo Tumor Imaging by Radiopharmaceuticals / Y.Ishii et al. / p301~301
  • 6.Cancer of Detection by Nuclear Magnetic Resonance Imaging / S.Sakuma / p302~302
  • 7.Digital Radiography / K.Hayashi / p303~303
  • 8.Not Received / /
  • Symposium10 Proper Indication of Cancer Chemotherapy / / p304~308
  • 1.An Analysis of Factors Affecting Clinical Cancer Chemotherapy / A.Wakui et al. / p304~304
  • 2.Current Trend of Phased Clinical Trials in Cancer Chemotherapy / M.Yokoyama / p305~305
  • 3.The Applicable Conditions to Gastric Cancer Chemotherapy / I.Nakao / p306~306
  • 4.Not Received / /
  • 5.Conditions Adaptive for the Adjuvant Chemotherapy of Gastric Cancer / T.Nakajima et al. / p307~307
  • 6.Controversial Points of Adjuvant Chemotherapy for Breast Cancer / Y.Nakano / p308~308
  • Symposium11 Evaluation of Cancer Chemotherapy by Second Look Operation / / p309~316
  • 1.Second Look Operation for Childhood Solid Malignany--With Special Reference to Primary Liver Carcinoma in Children / A.Toyosaka et al. / p309~309
  • 2.A New Chemotherapeutic Trial and Secondlook Operation in Childhood Solid Cancers / E.Arima / p310~310
  • 3.Second-look Operation for Glioblastoma and Chemotherapy / H.Yamamoto et al. / p311~311
  • 4.Intraarterial High-dose Adriamycin for Patients with Skeletal or Soft Tissue Sarcoma / S.Yoh et al. / p312~312
  • 5.Reoperation on the Evaluation of Adjuvant Immunochemotherapy for Non-curatively Resected Carcinoma of the Stomach / M.Niimoto et al. / p313~313
  • 6.Second Look Operation of Ovarian Malignancy / M.Yasuda et al. / p314~314
  • 7.Second Look Operation in Malignant Ovarian Tumors / A.Tsunawaki / p315~315
  • 8.Combined Modality for Recurrent and Disseminated Ovarian Cancer: CAPF Combination Chemotherapy and Second-look Operation / J.Inagaki et al. / p316~316
  • Symposium12 Progress in Radiation Therapy / / p317~323
  • 1.The Development of Modern Brachytherapy / Y.Shigematsu / p317~317
  • 2.Cf 252 Brachytherapy / K.Kaneta / p318~318
  • 3.Clinical Experience with Fast Neutron for Primary Lung Cancer / Y.Iino / p319~319
  • 4.Cancer Therapy by Hyperthermia / J.Egawa / p320~320
  • 5.Clinical Trials of Hypoxic Cell Sensitizer Misonidazole / Y.Onoyama / p321~321
  • 6.Computer Controlled Radiotherapy Planning and Radiotherapy / T.Matsuda / p322~322
  • 7.Intraoperative Radiotherapy for Locally Advanced Refractory Cancer / M.Abe et al. / p323~323
  • Panel Discussion1 New Methods for Cancer Diagnosis / / p324~328
  • 1.Determination of Serum Neuron-specific Enolase with Sensitive Enzyme Immunoassay and Its Evaluation as a Tumor Marker / Y.Ariyoshi et al. / p324~324
  • 2.New Diagnostic Method for the Detection of Metamorphosis in Superficial Bladder Cancer / K.Koiso et al. / p324~324
  • 3.Evaluation of Malignancy by Tissue Localization of Blood Group Antigens A,B,O(H)and Carcino-fetal Proteins (CEA,HCG) / S.Kodama et al. / p325~325
  • 4.Not Received / /
  • 5.The Diagnosis of Cervical Uterine Cancer by Flow-cytometry / T.Sugishita et al. / p325~325
  • 6.Diagnosis of Deep Involvement of Gastric Cancer by Infrared Laser Television Endoscopy / S.Mimura et al. / p326~326
  • 7.Bronchoscope Diagnostic System for Cancer Using Hematoporphyrin Derivative / K.Aizawa et al. / p326~326
  • 8.Mass Screening and Diagnosis of Laryngeal Cancer / S.Ebihara et al. / p327~327
  • 9.Recent Advance in Ultrasound Diagnosis of Ovarian Malignancy / H.Takeuchi et al. / p327~327
  • 10.Emission CT / K.Torizuka / p328~328
  • Panel Discussion2 New Methods for Cancer Therapy / / p329~334
  • 1.Colony Growth in Soft Agar by Various Malignant Cells of Cancer Patients and Its Application to Chemosensitivity Test / K.Inoue et al. / p329~329
  • 2.Usefulness of Tumor Stem Cell Assay in Cancer Chemotherapy / S.Hiraki et al. / p329~329
  • 3.Evaluation for Stem Cell Assay Using Animal Model and Clinical Samples / N.Yamamoto et al. / p330~330
  • 4.Scintillation Assay for Evaluation of the Chemosensitivity of Human Tumors / N.Tanigawa / p330~330
  • 5.Development of Electromagnetic Wave Heating Equipment for Cancer Therapy / M.Hiraoka et al. / p331~331
  • 6.BSD Hyperthermia System and Cancer Treatment / M.Kakehi et al. / p331~331
  • 7.Experimental Study on New Therapeutical Modalities of Bladder Cancer--Hyperthermia and Arterial Infusion of Anticancer Drugs by Means of Arterio-arterial Scribner Shunt in Internal Iliac Artery / T.Okabe et al. / p332~332
  • 8.Extracorporeally Induced Total-body Hyperthermia / N.Kato et al. / p332~332
  • 9.Laser Photoradiation Therapy with Hematoporphyrin Derivative in Malignant Tumors / H.Kato et al. / p333~333
  • 10.Study on the Treatment of Cervical Intraepithelial Neoplasia by CO₂ Laser Irradiation / S.Sekimoto et al. / p333~333
  • 11.Endoscopic Laser Treatment for Tumors of Gastrointestinal Tract / Y.Ito et al. / p334~334
  • Panel Discussion 3 Clinical Evaluation of Combined Therapy on Squamous Cell Carcinoma (I)Brain, Neck and Esophagus / / p335~339
  • 1.Results of Interstitial Radiotherapy for Cancer of the Tongue / J.Horiuchi et al. / p335~335
  • 2.Radium Therapy for Cancer of the Tongue / S.Kamata et al. / p335~335
  • 3.Treatment of Cancer of the Tongue and the Floor of Mouth in Kyushu Cancer Center--A Role of Radiation, Surgery and Chemotherapy / Y.Matsumura et al. / p336~336
  • 4.Long Term Results of Combined Therapy for Tongue Cancer / A.Konno et al. / p336~336
  • 5.Evaluation of Chemotherapy for Head and Neck Squamous Cell Carcinoma / Y.Inuyama et al. / p337~337
  • 6.Revaluation of Treatment of Carcinoma of the Hypopharynx with Special Reference to Radiation Therapy / T.Inoue et al. / p337~337
  • 7.Study in the Curative Radiotherapy of the Esophageal Cancer / T.Ohkawa et al. / p338~338
  • 8.Preoperative Therapy for Esophageal Carcinoma / T.Iizuka / p338~338
  • 9.Postoperative Cancer Therapy in Carcinoma of the Thoracic Esophagus Complying with the Extent of Lymphnode Metastasis / T.Nishihira et al. / p339~339
  • Panel Discussion4 Clinical Evaluation of Combined Therapy on Squamous Cell Carcinoma (II)Lung,Skin and Genital Organ / / p340~342
  • 1.The Role of Postoperative Radiation for the Bronchogenic Squamous Cell Carcinoma with Residual Tumor / R.Tsuchiya et al. / p340~340
  • 2.Effectiveness of a Sequential Combination of Bleomycin and Mitomycin-C on Advanced Bronchogenic Carcinoma--With Special Reference to Influence of Additional Radiotherapy / I.Kakusaka et al. / p340~340
  • 3.Benefit of Combination Therapy with Skin Cancer / K.Ishihara et al. / p341~341
  • 4.Preoperative Irradiation Therapy for the Uterine Cervical Cancer / F.Tsutsui et al. / p341~341
  • 5.A Combined Therapy of Surgery, Chemotherapy and Irradiation for Advanced Uterine Cervical Cancer / M.Iwasaki et al. / p342~342
  • 6.Results of Combination Therapy with Bleomycin and Radiation for Penile Cancer / K.Isurugi / p342~342
  • Panel Discussion5 Reconstruction in Cancer Therapy / / p343~346
  • 1.Primary Reconstruction of Head and Neck Defects Using Microsurgical Techniques / K.Harii et al. / p343~343
  • 2.Reconstructive Operation for Cancer Therapy Laryngo-tracheal Reconstruction for Surgical Treatment of Advanced Thyroid Cancer / M.Miyakawa et al. / p343~343
  • 3.Problems and Several Devices in Reconstruction of Cervical Esophagus / Y.Murakami / p344~344
  • 4.Surgical Treatment of Deep Ulcer of Chest Wall and Breast Reconstruction after Mastectomy / M.Bando / p344~344
  • 5.Discussion of Reconstructional Method for Chest-wall Defects after Resectable Operation of Malignant Tumors / M.Kitano et al. / p345~345
  • 6.Reconstruction of the Urinary Tract by Regeneration of the Bladder / H.Taguchi / p345~345
  • 7.The Reconstruction of the Groin and Perineum after the Surgical Excision of Malignant Lesions / Y.Nakayama et al. / p346~346
  • 8.Surgery for Restoration of the Functions of Soft Tissue and Bone Affected by Tumors / N.Kawaguchi et al. / p346~346
  • General Lecture 1.Clinical Significance of Ultrasonically Guided Puncture of Carcinoma of the Gallbladder / Y.Watanabe et al. / p347~347
  • General Lecture 2.Not Received / /
  • General Lecture 3.A New Method for the Detection of Minute Cancer of the Gastrointestine / M.Tada et al. / p347~347
  • General Lecture 4.The Use of Intraluminal Scanning(Echogastrofiberscope and Echolaparoscope)for the Detection of Intraabdominal Malignancies / M.Fukuda et al. / p348~348
  • General Lecture 5.Preoperative Evaluation of Abdominal Malignancy Using Dynamic CT--With Special Reference to Its Progression / M.Ozaki et al. / p348~348
  • General Lecture 6.Cancer Immunotherapy with in vitro Resensitized Autologous Lymphocyte / N.Kan et al. / p349~349
  • General Lecture 7.Two Chemosensitivity Tests(Microassay and Stem Cell Assay)for Urological Cancer / T.Miura et al. / p349~349
  • General Lecture 8.Drug Sensitivity Test of Cancer Cells by Use of Microtiter Plate and Cell Harvester / H.Ichihashi et al. / p350~350
  • General Lecture 9.Not Received / /
  • General Lecture 10.A New in vitro Sensitivity Test for Anti-tumor Agents: Fundamental Experiment and Its Clinical Application / M.Oguro et al. / p350~350
  • General Lecture 11.Pharmacokinetics of Marcomomycin / H.Majima et al. / p351~351
  • General Lecture 12.Clinical Studies on K-247: Single and Combined Administration for Cancer Patients / M.Oride et al. / p351~351
  • General Lecture 13.Clinical Study of HCFU for Head and Neck Cancer / T.Honda et al. / p352~352
  • General Lecture 14.Action Mechanism of Aclarubicin in Leukemic Cells and Its Clinical Effects / T.Nakamura et al. / p352~352
  • General Lecture 15.Diagnostic Significance of Myocardial Scintigram in Adriamycin-induced Cardiotoxicity / H.Ueoka et al. / p353~353
  • General Lecture 16.Clinical Appraisal of a New FUDR Derivative,FF-705 / K.Yunoki et al. / p353~353
  • General Lecture 17.Clinical Experiences with MCNU / H.Furue et al. / p354~354
  • General Lecture 18.Phase I Clinical Trial of 4'-O-Tetrahydropyranyladriamycin (THP-ADM) / H.Miyamoto et al. / p354~354
  • General Lecture 19.Phase I and Preliminary Phase II Study on CAM (Ethyl o-[N-(p-carboxyphenyl)-carbamoyl]-mycophenolate) / M.Sakuma et al. / p355~355
  • General Lecture 20.Early Phase II Study of PL-AC[N⁴-palmitoyl-(1-ß-D-arabinofuranosyl) cytosine]on Hematopoietic Malignancies / T.Takubo et al. / p355~355
  • General Lecture 21.The Value and Future Potential of Radiotherapy in the Management of Esophageal Cancer / T.Nakano et al. / p356~356
  • General Lecture 22.Radiation Therapy for Carcinoma of the Esophagus / T.Ishikawa et al. / p356~356
  • General Lecture 23.The Results of the Radiotherapy of Esophageal Carcinomas and Its Tomorrow's Direction / M.Nishio et al. / p357~357
  • General Lecture 24.Combination Therapy with Radiation and Bleomycin for Esophageal Carcinoma--With Special Reference to the Prognostic Aspect / S.Yamada et al. / p357~357
  • General Lecture 25.The Clinical Experience of Cisplatin Administrated for Esophageal Cancer / M.Kimura et al. / p358~358
  • General Lecture 26.Intraoperative Adjuvant Chemotherapy for Esophageal Carcinoma / K.Sugimachi et al. / p358~358
  • General Lecture 27.Clinical Application of Microencapsulated Anticancer Drug VII. Clinical Application of Microencapsulated Peplomycin / M.Shindo et al. / p359~359
  • General Lecture 28.Histological Transition of PLM and Its Effects to Cervical Cancer of Uterus / K.Katoh et al. / p359~359
  • General Lecture 29.Administration of Anticancer Agents into the Pleural Lymphatics and Mediastinal Lymph Nodes during Thoracotomy / Y.Ueno et al. / p360~360
  • General Lecture 30.Continuous Subcutaneous Infusion of Pepleomycin for Head and Neck Cancer--With Special Reference to Pharmakokinetics / M.Fujii et al. / p360~360
  • General Lecture 31.Peplomycin Treatment for Cancer of the Thyroid / Y.Kure et al. / p361~361
  • General Lecture 32.Interferon Therapy for Brain Tumor Patients: General and Local Administration / S.Ueda et al / p361~361
  • General Lecture 33.Antitumor Activity of Human-interferon-ß against Malignant Brain Tumors / T.Wakabayashi et al. / p362~362
  • General Lecture 34.Therapeutic Effect of Hu-Interferon-ß and Interferon Inducer (Poly ICLC) in the Malignant Brain Tumors / O.Nakamura et al. / p362~362
  • General Lecture 35.Serial Changes of Serum Interferon Concentrations after Human Fibroblast Interferon Adminis trations in the Patients with Hepatocellular Carcinoma (HCC) and Metastatic Liver Cancer / T.Okai et al. / p363~363
  • General Lecture 36.Clinical Evaluation of Human Lymphoblastoid Interferon (HLBI) in the Treatment of Advanced Cancer / Y.Ariyoshi et al. / p363~363
  • General Lecture 37.Human Lymphoblastoid Interferon Therapy in Advanced Renal Cell Carcinoma / M.Murai et al / p364~364
  • General Lecture 38.Combination Chemotherapy for Adenocarcinoma of the Lung with Adriamycin,ACNU,and Vindesine / S.Yoneda et al. / p364~364
  • General Lecture 39.A Combination of ACNU and MMC as an Adjuvant Chemotherapy for Patients with Lung Cancer / K.Matsumura et al. / p365~365
  • General Lecture 40.Phase II Study of Vindesine in Patients with Carcinoma of the Lung and Metastatic Pulmonary Tumor / M.Shibuya et al. / p365~365
  • General Lecture 41.Combination Chemotherapy of Small Cell Lung Cancer with Vincristine,Etoposide,and Cyclophosphamide / K.Aiba et al. / p366~366
  • General Lecture 42.Clinical Study of Combination Chemotherapy with Cis-Diamminedichloroplatinum (CDDP), Peplomycin (PEP)and Mitomycin C(MMC) (PPM Therapy) / T.Goto et al. / p366~366
  • General Lecture 43.Vindesine in the Treatment of Recurrent or Advanced Lung Cancers / T.Sakai et al. / p367~367
  • General Lecture 44.Evaluation of Intra and Rotter Lymph Nodes Dissection Regarding to the Indications of Modified Radical Mastectomies / A.Fukami et al. / p367~367
  • General Lecture 45.Studies on Local Recurrence of Breast Cancer / T.Ikeda et al. / p368~368
  • General Lecture 46.Analyses of Bone Metastasized Cases after Radical Mastectomy for Breast Cancer / H.Abe et al. / p368~368
  • General Lecture 47.Clinicopathological Examination of Early Stomach Cancers of which Depth of Invasions were Wrongly Diagnosed Preoperatively / H.Kotanagi et al. / p369~369
  • General Lecture 48.Bone Metastasis of Stomach Carcinoma / K.Yoshikawa et al. / p369~369
  • General Lecture 49.Bone Marrow Metastasis of the Gastric Carcinoma and Leukemoid Reaction / S.Harashima et al. / p370~370
  • General Lecture 50.Ratio of Urinary 11-deoxy-17-oxosteroids to 17-hydroxycorticosteroids as a Guide to the Prognosis in Breast Cancer / Y.Nakamura et al. / p370~370
  • General Lecture 51.Obesity and Impaired Glucose Tolerance as Breast Cancer Risk Factors / S.Miura et al. / p371~371
  • General Lecture 52.Multiple Hormonal Analysis in Normal Women and in Patients with Breast Cancer / E.Imayoshi et al. / p371~371
  • General Lecture 53.Clinical Evaluation of Bone Scanning and Carcinoembryonic Antigen in Patients with Breast Cancer / M.Kitamura et al. / p372~372
  • General Lecture 54.Histochemical Analysis of T Cell Subsets Infiltration in Human Breast Cancer Tissues / T.Usui et al. / p372~372
  • General Lecture 55.Effect of Cyclophosphamide and 5-FU on IgG FcR⁺ T-Cell(Tγ)in Patients with Breast Cancer / M.Kimura et al. / p373~373
  • General Lecture 56.The Value of Carcitonin and CEA in Connection with the Morbid State of Medullary Carcinoma of Thyroid / T.Bessho et al. / p373~373
  • General Lecture 57.Further Examination of CEA in Patients with Lung Cancer / Y.Matsubara et al. / p374~374
  • General Lecture 58.Postoperative CEA Monitoring in Patients with Gastric Cancer / Y.Hiramoto et al. / p374~374
  • General Lecture 59.Relation between Accumulation of ¹²⁵I-Labeled Anti-CEA in Cancer Tissue and CEA Level in Plasma / A.Ohashi et al. / p375~375
  • General Lecture 60.Studies on Plasma Level of Carcinoembryonic Antigen(CEA)Correlating to Tissue Content and Microangiographic Patterns in Colorectal Cancer / T.Shimoyama et al. / p375~375
  • General Lecture 61.Immuno-histological Studies of Carcinoembryonic Antigen in Malignant Gynecologic Tumor / T.Ishikawa et al. / p376~376
  • General Lecture 62.Influence of Host's Immunological Competence on Human Gastric Carcinomas Transplanted into Nude Mice--With Special Reference to NK Cells / H.Konno et al. / p376~376
  • General Lecture 63.The Effects of IFN(Interferon)on Murine Syngeneic Murine Malignant Glioma-specific Killer T Cell / T.Yamasaki et al. / p377~377
  • General Lecture 64.NK Activity of Oral Cancer Patients / T.Tagami et al. / p377~377
  • General Lecture 65.Natural Killer(NK)Activity in the Patients with Thyroid Cancer / N.Aoki et al. / p378~378
  • General Lecture 66.Influence of Surgical Operation and Chemotherapy against NK Activity in Cancer Patients / T.Beika et al. / p378~378
  • General Lecture 67.Cell-mediated Immune Response of Regional Lymph Nodes in Patients with Carcinoma / F.Koba et al. / p379~379
  • General Lecture 68.Pathohistological and Immunological Research of Spontaneous Regression or Long Survival Cancer Cases(VIII) -On Local Lymphocyte infiltration and Immunological Alteration of Long Survival Cases of Cancer Patients / S.Nakagawa et al. / p379~379
  • General Lecture 69.The Effect of Splenectomy on Cell-mediated Immunological Dynamics after Operation in the Patients with Gastric Cancer / Y.Fuyuhiro et al. / p380~380
  • General Lecture 70.Diagnosis of Cancer Using the Changes of Electrophoretic Mobility in Peripheral Lymphocytes / T.Mori et al. / p380~380
  • General Lecture 71.Studies on the Cellular Immune Response in Patients with Urinary Bladder Carcinoma / S.Nishio et al. / p381~381
  • General Lecture 72.Detection of Immune Complexes in Patients with Head and Neck Tumor and Evaluation of Its Diagnostic Value / S.Yoshinoya et al. / p381~381
  • General Lecture 73.The Analysis of Cytostatic Activity of Human Peripheral Blood Granulocytes and Its Augmentation with Biological Response Modifiers (BRM) / T.Takisawa et al. / p382~382
  • General Lecture 74.Suppressive Effect of Mitomycin C Injection via the Hepatic Artery or Splenic Vein on Implantation of Vx2 in Liver / B.Izumi et al. / p382~382
  • General Lecture 75.Studies on the Host Immune Response in Rat during Induction of Bladder Tumors by BBN / Y.Ozaki et al. / p383~383
  • General Lecture 76.Usefulness of Immunosuppressive Acidic Alpha-2 Macroglobulin as a Tumor Marker / A.Ikeda et al. / p383~383
  • General Lecture 77.Comparative in vitro Immunological Studies in Cryosurgery and Surgical Resection Using Spontaneous Murine Mammary Carcinoma(C42),in DS Mice / N.Kohno et al. / p384~384
  • General Lecture 78.The Clinical Significance of Serum Ribonuclease Activity in Patients with Cancer / M.Hakosaki et al. / p384~384
  • General Lecture 79.Study on Relationship between Vitamin Status and Nutritional,Immunological Parameters in Gastric Cancer Patients / K.Shirasawa et al. / p385~385
  • General Lecture 80.Renal Cell Carcinoma,Histological Features Affecting Prognosis, 2nd Report, Histological Features Affecting Prognosis / T.Onishi et al. / p385~385
  • General Lecture 81.Plasma Prostaglandin E for Renal Cell Carcinoma / I.Satake et al. / p386~386
  • General Lecture 82.Pre-and Postoperative Changes of Serum Proteins in Renal Cancer Patients / H.Hisazumi et al. / p386~386
  • General Lecture 83.Leukocyte Adherence Inhibition(LAI)Assay in Renal Cancer / Y.Okada et al. / p387~387
  • General Lecture 84.Study of Postoperative Lung Metastases from Renal Cell Carcinoma / T.Murase et al. / p387~387
  • General Lecture 85.Combined Chemotherapy for Advanced Renal Cell Carcinoma with Doxorubicin Hydrochloride and Carboquone / T.Osawa et al. / p388~388
  • General Lecture 86.Polyamines as Biochemical Marker of Malignant Bladder Tumors / H.Kiyohara et al. / p388~388
  • General Lecture 87.Correlations between Bladder Tumor Patients and Cellular Immunological Status / M.Hata et al. / p389~389
  • General Lecture 88.Clinical Studies on Serum IAP(Immunosuppressive Acid Protein)Levels in Genitourinary Cancer Patients / H.Kumon et al. / p389~389
  • General Lecture 89.Pregnancy Associated α₂-Glycoprotein in Urogenital Malignancies / H.Hisazumi et al. / p390~390
  • General Lecture 90.Localization of the HCG-like Substance in the Testicular Tumors / S.Goto et al. / p390~390
  • General Lecture 91.Radioimmunodetection of Choriocarcinoma in Nude Mouse by Radiolabeled Antibodies to Human Chorionic Gonadotropin / N.Yamanaka et al. / p391~391
  • General Lecture 92.Treatment of Advanced Urogenital Cancer with Cis-diamminedichloroplatinum (CDDP) / K.Suzuki et al. / p391~391
  • General Lecture 93.Vincristine,Peplomycin,Methotrexate,Cis-platinum,Cytosine Arabinoside and 5-FU,Multidrug Sequential Combination Chemotherapy(VPM-CisCF Regimen)for Urogenital Malignancies / T.Yamauchi et al. / p392~392
  • General Lecture 94.A Clinical Trial of Combination Chemotherapy with VCR,BLM(PEP),MMC,FT 207 and OK 432 in Urothelial Tumor(II) / S.Fujihiro et al. / p392~392
  • General Lecture 95.Evaluation of Antitumor Agents Containing Polymerized Capsule for the Treatment of Urological Cancer / M.Takara et al. / p393~393
  • General Lecture 96.Combination Chemotherapy with Bleomycin,Vincristine and Methotrexate for Stage I Nonseminomatous Germ Cell Testicular Tumors / I.Fukui et al. / p393~393
  • General Lecture 97.Study of Chemotherapy of Testicular Tumors Transplanted into Nude Mice--Revised Regimens of PVB Therapy by Using Vincristine and VP-16-213 / K.Okada et al. / p394~394
  • General Lecture 98.Three Cases with Carcinoma in Situ of the Upper Urinary Tract Diagnosed by Urinary Cytology / T.Yagishita et al. / p394~394
  • General Lecture 99.The Clinical Study of Urinary Cytology / S.Nemoto et al. / p395~395
  • General Lecture 100.Histopathological Evaluation on Bladder Epithelium by Random Cold Cup Biopsies in Patients Treated with Periodic Prophilactic Bladder Instillation of Anticancer Drugs / M.Nakao et al. / p395~395
  • General Lecture 101.Role of Radioisotope Angiography in Evaluation of Intra-arterial Infusion Therapy of Bladder Cancer / S.Ishikawa et al. / p396~396
  • General Lecture 102.Multiple Random Mucosal Biopsy with Transurethral Resection of Bladder Tumor: Part 2 / M.Nagata et al. / p396~396
  • General Lecture 103.TUSR-Bt after Selective Transcatheter Embolization of Vesical Artery / H.Fujioka et al. / p397~397
  • General Lecture 104.Comparative Clinical Study of Bladder Instillation Therapy Using Several Anticancerous Drugs / M.Maegawa et al. / p397~397
  • General Lecture 105.Clinical Study on Prophylactic Intravesical MMC Instillation Therapy for Bladder Cancer / C.Yasumuro et al. / p398~398
  • General Lecture 106.Experimental Study on Chemotherapy for Urinary Bladder Cancer: Intraarterial Infusion of High Dose CDDP with a Concomitantly Used Direct Hemoperfusion / Y.Nakano et al. / p398~398
  • General Lecture 107.In vitro Sensitivity of Five Established Bladder Cancer Cell Lines to Anticancer Drugs--Synchronization Technique with BLM,VCR and C-DDP / H.Afuso et al. / p399~399
  • General Lecture 108.Comparison between FT-207 and 5-FU on Intravesical Absorption / S.Nakagawa et al. / p399~399
  • General Lecture 109.Monitoring the Efficacy of Bladder Cancer Treatment by Sequential Flow-cytometric DNA Analysis / K.Yoshikawa et al. / p400~400
  • General Lecture 110.Cutaneous Ureteroureterostomy (Catheterless-method) / K.Matsumoto et al. / p400~400
  • General Lecture 111.Treatment of Percutaneous Transrenal Urinary Tract Drainage(PTUD)on Advanced Cancer with Urinary Tract Obstruction / Y.Maruyama et al. / p401~401
  • General Lecture 112.The Prognosis of Total Cystectomy and Ureterosigmoidostomy for Bladder Cancer--Some Histological Aspects and Clinical Studies / J.Satoh et al. / p401~401
  • General Lecture 113.Total Cystectomy for Bladder Tumor / K.Okada et al. / p402~402
  • General Lecture 114.The Quality of Life of the Patients after Radical or Total Cystectomy with Ileal Conduit / O.Yoshida et al. / p402~402
  • General Lecture 115.Prognostic Factors in Invasive Bladder Carcinoma / M.Kuroda et al. / p403~403
  • General Lecture 116.An Immunological Diagnosis of Prostate Cancer / M.Kuriyama et al. / p403~403
  • General Lecture 117. Immunoadsorbent Assay for Serum Prostatic Acid Phosphatase with Prostatic Carcinoma Patients / Y.Sato et al. / p404~404
  • General Lecture 118.Evaluation of Serum Prostate-specific Antigen in Urological Cancers / T.Takeuchi et al. / p404~404
  • General Lecture 119.DNA Content in Cells Aspirated from Carcinoma of Prostate / Y.Fujimoto et al. / p405~405
  • General Lecture 120.The Measurement of Serum Prostatics Antigens(γ-Seminoprotein and β-Microseminoprotein) by Radioimmunoassay / T.Okabe et al. / p405~405
  • General Lecture 121.Urinary Hydroxyproline Excretion as a Marker of Bone Metastasis in Prostatic Cancer(II) / K.Rinsho et al. / p406~406
  • General Lecture 122.Chemotherapy of Advanced Prostatic Carcinoma / M.Usami et al. / p406~406
  • General Lecture 123.Clinical and Statistical Observation of In-Patients with Prostatic Cancer / T.Saiki et al. / p407~407
  • General Lecture 124.Factors Influencing Prognosis of Prostatic Cancer / T.Masukagmi et al. / p407~407
  • General Lecture 125.Not Received / /
  • General Lecture 126.Prostatic Cancer Pathological Analysis of Autopsied Cases / K.Ando et al. / p408~408
  • General Lecture 127.In vitro Antitumor Activity of a New Compound,7-N-(p-Hydroxyphenyl)-Mitomycin C(KW-2083)against Human Tumor Cell Lines,Compared with Mitomycin C (MMC) / E.Shimizu et al. / p408~408
  • General Lecture 128.Clinical Evaluation of KW2083 / K.Hasegawa et al. / p409~409
  • General Lecture 129.Phase II Group Study on a Mitomycin Derivative,KW 2083 / M.Shimizu et al. / p409~409
  • General Lecture 130.Clinical Study of KW2083(MMC Derivative)for Lung Cancer / S.Negoro et al. / p410~410
  • General Lecture 131.Treatment of Various Malignant Tumors with KW2083(Second Report) / T.Yokoyama et al. / p410~410
  • General Lecture 132.Clinical Experience with M 83 / H.Majima / p411~411
  • General Lecture 133.The Extension of Non-Hodgkin's Lymphoma and Lymphographic Findings / S.Matsubara et al. / p411~411
  • General Lecture 134.Staging Laparotomy in Malignant Lymphoma / Y.Kurosu et al. / p412~412
  • General Lecture 135.Clinico-pathological Study on the Primary Malignant Lymphomas of the Stomach / Y.Ohmori et al. / p412~412
  • General Lecture 136.The Treatment Results of Non-Hodgkin Lymphoma in the Head and Neck Region / K.Sakaino et al. / p413~413
  • General Lecture 137.Hodgkin Disease Treatment Results and Prognosis / S.Hamada et al. / p413~413
  • General Lecture 138.Trial of Remission Induction by Treatment of Vincristine,Bleomycin and a Massive Dose of Prednisolone in Lymphoma Patients with Markedly Compromized Bone Marrow / K.Tamura et al. / p414~414
  • General Lecture 139.A Study of Surface Phenotype and Response to Chemotherapy of Patients with T Cell Leukemia in Adult / I.Tanaka et al. / p414~414
  • General Lecture 140.DNA Excision Repair of Human Leukemia Cells Following Ultraviolet Radiation / S.Atumi et al. / p415~415
  • General Lecture 141.Clinical Effect of V'P-DV'MP and V'AP Regimen for Acute Lymphocytic Leukemia in Adults / K.Uchida et al. / p415~415
  • General Lecture 142.Clinical Study of Bestatin(NK-421)-an Immunopotentiator-in Patients with Hemopoietic Malignancies & Solid Tumors / T.Sugano et al. / p416~416
  • General Lecture 143.Updated Results of Vindesine in the Treatment of Lymphoma and a Comparative Study in vitro of Vincristine and Vindesine / M.Nishikori et al. / p416~416
  • General Lecture 144.Combination Chemotherapy of Multiple Myeloma with Melphalan,Cyclophosphamide,Prednisone,Vincristine and ACNU
  • Modified M₂ Protocol / Y.Iwata et al. / p417~417
  • General Lecture 145.Actual State of Cervical Cancer / Y.Nakagiri et al. / p417~417
  • General Lecture 146.Treatment of Para-aortic Nodes Metastases from Carcinoma of the Uterine Cervix and Usefulness of CT Scan / S.Kubota et al. / p418~418
  • General Lecture 147.The Result for Squamous Cell Carcinoma of the Cervix Uteri in the Early Stage by External Radiation Therapy Alone / I.Azuma / p418~418
  • General Lecture 148.A Study of Risk Factors Relating to Metastasis of the Uterine Cervical Cancer--Analyses of Lymph Node Involvement Negative Case / J.Ishii et al. / p419~419
  • General Lecture 149.Radical Surgery vs.Radiotherapy in Squamous Cell Carcinoma of the Uterine Cervix Stage I and II / H.Noguchi et al. / p419~419
  • General Lecture 150.Intracavitary Irradiation Following Radical Hysterectomy for Invasive Cervical Carcinoma / N.Furuta et al. / p420~420
  • General Lecture 151.Tissue Localization and Plasma Value of Carcino-embryonic Antigen in Adenocarcinoma of the Uterine Cervix / Y.Okudaira et al. / p420~420
  • General Lecture 152.The Controversail Point in Treatment of the Aged Cervical Cancer / A.Takano et al. / p421~421
  • General Lecture 153.Radiation Therapy in Carcinoma of the Uterine Cervix in Aged Patients / S.Wada et al. / p421~421
  • General Lecture 154.Study on the Significance of So-called Preoperative Irradiation for Stage III Uterine Cervical Cancer / M.Hayafuji et al. / p422~422
  • General Lecture 155.Results of Radiotherapy by RALSTRON for Uterine Cervical Cancer / S.Sato et al. / p422~422
  • General Lecture 156.The Studies for Late Recurrence of Uterine Cervical Cancer / J.Umezu et al. / p423~423
  • General Lecture 157.A Study of Prognostic Factors for Choriocarcinoma / K.Miyazaki et al. / p423~423
  • General Lecture 158.A Study on Pulmonary Metastases of Chorionic Disease / T.Fuchi et al. / p424~424
  • General Lecture 159.Not Received / /
  • General Lecture 160.Clinical Studies on Patients with Intrathecal Metastases in Choriocarcinoma / K.Kanazawa et al. / p424~424
  • General Lecture 161.Immune-capacity in the Patients with Trophoblastic Tumor / N.Mano et al. / p425~425
  • General Lecture 162.On Chemotherapy in Treatment and Management of Molar Patients / T.Suzuki et al. / p425~425
  • General Lecture 163.Clinical Study of Endometrial Carcinoma / T.Jobo et al. / p426~426
  • General Lecture 164.A Study of Factors Affecting Prognosis of Endometrial Cancer Treated with Operation / F.Araki et al. / p426~426
  • General Lecture 165.Prognosis of the Endometrial Cancer after Five Year Survivals / I.Fujimoto et al. / p427~427
  • General Lecture 166.Treatment of Ovarian Carcinomas and Their Prognosis / H.Kawauchi et al. / p427~427
  • General Lecture 167.A Study of Malignant Common Epithelial Tumors of the Ovary with Special References to Treatment and Prognosis / K.Hiramatsu et al. / p428~428
  • General Lecture 168.Therapeutic Results of Malignant Ovarian Tumor / I.Fukazawa et al. / p428~428
  • General Lecture 169.Combination Chemotherapy Containing Cisplatin in Malignant Ovarian Carcinoma
  • The Role of Completeness of Surgical Treatment / H.Yoshikawa et al. / p429~429
  • General Lecture 170.Study on Single Therapy Using Cis-DDP for Progressive Ovarian Cancer / K.Niitsuma et al. / p429~429
  • General Lecture 171.UFT-M Chemotherapy for Ovarian Cancer(No.2) / Y.Uchida et al. / p430~430
  • General Lecture 172.Not Received / /
  • General Lecture 173.On the Role of"Second Look Operation"in Management of Malignant Epithelial Tumor of the Ovary / T.Hando et al. / p430~430
  • General Lecture 174.Management of Endodermal Sinus Tumor with Chemotherapy-resistance / T.Tazaki et al. / p431~431
  • General Lecture 175.Study on the Follow-up of Screening for Cancer of the Uterine Cervix / S.Sekimoto et al. / p431~431
  • General Lecture 176.Individual Analysis of the Candidates for Uterine Cancer Mass Screening through the Car by Single Organization / M.Fujiwara et al. / p432~432
  • General Lecture 177.Not Received / /
  • General Lecture 178.A Study of the Cause of Death on Carcinoma of the Cervix / M.Takahashi et al. / p432~432
  • General Lecture 179.Clinical and Pathological Research of Adenocarcinoma of the Cervix Uteri / H.Nishi et al. / p433~433
  • General Lecture 180.Application of Radial Scan Ultrasonography(RSUSG)for Estimating the Extension of Cervical Cancer / N.Akamatsu et al. / p433~433
  • General Lecture 181.Not Received / /
  • General Lecture 182.The Value of Cervicoscopy on Endocervical Lesion / S.Katayama et al. / p434~434
  • General Lecture 183.Not Received / /
  • General Lecture 184.Not Received / /
  • General Lecture 185.Evaluation of Small Fractionation(16 Fractions/4 Weeks)for Uterine Cervical Cancer / J.Mizoe et al. / p434~434
  • General Lecture 186.Quantitative Measurement of the Survival Rate of Human Tumor Cells Transplanted in the Nude Mice / S.Mitsunaga et al. / p435~435
  • General Lecture 187.Protective Effect of Superoxide Dismutase on Intestinal Radiation Injury / Y.Watanabe et al. / p435~435
  • General Lecture 188.Not Received / /
  • General Lecture 189.The Prognosis of the Exploratory-operated Patients with the Cervical Cancer / T.Kasamatsu et al. / p436~436
  • General Lecture 190.Extension of Cervical Cancer of Uterus to Ovary and Operative Choice of Ovarian Preservation / K.Katoh et al. / p436~436
  • General Lecture 191.Tumor of the Vagina Following Radical Hysterectomy for Uterine Cervical Carcinoma / N.Chen et al. / p437~437
  • General Lecture 192.Not Received / /
  • General Lecture 193.A Case Report of 17 Year Old Girl with Cervical Carcinoma / Y.Sakai et al. / p437~437
  • General Lecture 194.Adjuvant Therapy of Corpus Cancer--Large Dose Long Term Administration of Progesterone / M.Hirono et al. / p438~438
  • General Lecture 195.Model Experiments of Nude Mouse for Hormone Therapy to Endometrial Carcinoma / Y.Nishida et al. / p438~438
  • General Lecture 196.Correlation of Androgen Receptors with the Histologic Grade of Differentiation of Human Endometrial Carcinomas / J.Kato et al. / p439~439
  • General Lecture 197.The Significance of Human Keratin Proteins hKP in Endometrial Carcinoma / M.Hatae et al. / p439~439
  • General Lecture 198.Estrogen and Progesterone Interaction on Rat Uterus / S.Sakamoto et al. / p440~440
  • General Lecture 199.The Nature of hCG in Partial Hydatidiform Mole / S.Imamichi et al. / p440~440
  • General Lecture 200.Specific Effects of MTX Bound to the Antibodies against hCG and Placental Alkaline Phosphatase to the Cultured Human Choriocarcinoma Cells / S.Hattori et al. / p441~441
  • General Lecture 201.Placental Protein PP5 Behaviors in Patients with Trophoblastic Diseases / K.Isaka et al. / p441~441
  • General Lecture 202.Not Received / /
  • General Lecture 203.A Case of Chorionic Disease in Which a Dissociation of the hCG Level was Seen in the Blood and Urine / H.Deguchi et al. / p442~442
  • General Lecture 204.Not Received / /
  • General Lecture 205.Predictability of Chemosensitivity Patterns of Human Gastric Cancer-Nude Mouse Pannel to Clinical Response of Anticancer Drugs / M.Fujita et al. / p442~442
  • General Lecture 206.Not Received / /
  • General Lecture 207.Sensitivity Test of Anticancer Agents Using Human Tumor Xenografts in Nude Mice with Special Reference on Correlation between Post-operative Course and Chemosensitivity for Gastric Cancer / Y.Noso et al. / p443~443
  • General Lecture 208.An Evaluation of Anticancer Effect of Chemotherapeutic Agents on ENNG-induced Canine Gastric Cancer / A.Nakashima et al. / p443~443
  • General Lecture 209.Experimental Chemotherapy on Human Digestive Carcinomas Serially Transplantable into Nude Mice / E.Kawamura et al. / p444~444
  • General Lecture 210.In vitro Sensitivity Test of Human Solid Cancer,Serially Transplanted to Nude Mice / Y.Hanatani et al. / p444~444
  • General Lecture 211.Nonspecific Immune Suppression in Gastric Cancer Patients / H.Nakanishi et al. / p445~445
  • General Lecture 212.Observation of Histological Types in Advanced Stomach Cancer Patients: An Examination of Immunological Parameters / T.Taira et al. / p445~445
  • General Lecture 213.The Relationship of Immunocompetence between Specific Cytotoxicity and Non-specific Immunological Parameters in Gastric Cancer Patients / Y.Sugiyama et al. / p446~446
  • General Lecture 214.PHA and PPD Skin Reaction in Patients with Gastric Cancer / K.Futatsuki et al. / p446~446
  • General Lecture 215.Not Received / /
  • General Lecture 216.Study for Immunoresponce to Regional Lymphnode on the Gastric Cancer / S.Kitasato et al. / p447~447
  • General Lecture 217.Clinical Significance of Immunosuppressive Substance(ISS)in the Serum of Patients with Gastric and Colorectal Cancer / S.Fuchimoto et al. / p447~447
  • General Lecture 218.Postoperative Changes in Serum Ferritin and Immunosuppressive Acid Protein(IAP) Levels in Gastric Cancer Patients / Y.Yokoyama et al. / p448~448
  • General Lecture 219.Acute Phase Reactants in Patients with Gastric Carcinoma / K.Ogoshi et al. / p448~448
  • General Lecture 220.A Study on Natural Killer Cell Activity in the Patients with Cancer of Digestive Tract(Second Report) / H.Matsumoto et al. / p449~449
  • General Lecture 221.Serum Lysozyme Activities with Schizophyllan / H.Itoh et al. / p449~449
  • General Lecture 222.Clinical Significance of Specific Immune Complex and Monoclonal Antibody to Basic Fetoprotein / Y.Kanda et al. / p450~450
  • General Lecture 223.Gastric,Pancreatic and Biliary Excretion of Fluorinated Pyrimidines in Dogs / K.Miyasaka et al. / p450~450
  • General Lecture 224.The Effectiveness of 1-hexylcarbamoyl-5-fluorouracil(HCFU)on Carcinomatous Pleural Effusions or Ascites / Y.Abe et al. / p451~451
  • General Lecture 225.Blood Levels of 1-Hexylcarbamoyl-5-Fluorouracil(HCFU)and 5-FU on Oral Administration of HCFU in Patients with Primary Hepatoma / H.Kondo et al. / p451~451
  • General Lecture 226.Enzymatic Conversion of Tegafur(FT 207)to 5-Fluorouracil(5Fu)in Human Tumor Tissues / Y.Hara et al. / p452~452
  • General Lecture 227.Clinical Evaluation of KW-5338 Against the Side-effects(Nausea and Vomiting)Induced by Antineoplastic Agents / C.Lu et al. / p452~452
  • General Lecture 228.Prevention from Side-effects of Chemotherapy for Cancer of the Gastrointestinal tract with Domperidone / H.Sugiura et al. / p453~453
  • General Lecture 229.Correlation of Tissue CEA Localization with Clinical Features and Prognosis in Colorectal Carcinoma / Y.Hamada et al. / p453~453
  • General Lecture 230.Pancreatic Oncofetal Antigen(POA)
  • Its Significance as a Marker of Pancreatic Cancer / K.Nishida et al. / p454~454
  • General Lecture 231.Study for Isoelectric Focusing of RNase in Serum from Rat with Pancreatitis and Pancreatic Cancer / C.Fujimori et al. / p454~454
  • General Lecture 232.Diagnosis of Liver Metastases with 5'-Nucleotide Phosphodiesterase Isoenzyme-V(5'-NPD-V)Test / H.Ogiwara et al. / p455~455
  • General Lecture 233.Detection of Liver Metastasis with Serum 5'-Nucleotide Phosphodiesterase Isozyme-V(5'-NPDase-V)in Gastrointestinal Cancer Patients / H.Tomoda et al. / p455~455
  • General Lecture 234.Comparative Study of Serum Elastase 1 to Other Tumor Markers in Patients with Pancreatic Cancer / A.Honma et al. / p456~456
  • General Lecture 235.A Comparison of Survival Rates in Head and Neck Cancer / B.Satake et al. / p456~456
  • General Lecture 236.Reconstruction Following Resection of Oral and Mesopharyngeal Tumor / F.Sato et al. / p457~457
  • General Lecture 237.Two Cases of Triple Primary Cancers / M.Miyata / p457~457
  • General Lecture 238.Autopsy Findings of 2 Cases of Maxillary Carcinoma with Abdominal Metastasis / S.Makino et al. / p458~458
  • General Lecture 239.Not Received / /
  • General Lecture 240.Prognosis for Long-term Survived Patients of Oral Cancer Treated with Radiation / J.Horiuchi et al. / p458~458
  • General Lecture 241.The Reference Point of Dose Calculation in Ra Interstitial Radiotherapy of Tongue Carcinoma / S.Satoh et al. / p459~459
  • General Lecture 242.Analysis of Cases with Nasopharyngeal Epidermoid Cancer Who Had Local Recurrence after Initial Radiation Therapy / N.Mitsuhashi et al. / p459~459
  • General Lecture 243.Immunological Reactivity of Patients with Malignant Tumor of the Head and Neck / K.Sakaguchi et al. / p460~460
  • General Lecture 244.Treatment of Nasopharyngeal Cancer--Effect of Peplomycin on NPC / O.Semba et al. / p460~460
  • General Lecture 245.Adriamycin Ointment for Treatment of Recurrent Cancer in Head and Neck / Y.Nakashima et al. / p461~461
  • General Lecture 246.Head and Neck Mucosal Malignant Melanomas--A Long Term Survival Case / N.Soh et al. / p461~461
  • General Lecture 247.Multi-disciplinary Treatment for Malignant Melanoma of the Nose and Paranasal Sinuses / H.Saito / p462~462
  • General Lecture 248.A Treatment for Malignant Melanoma of Nasal Cavity and Knee Region / A.Fujino et al. / p462~462
  • General Lecture 249.A Case of Amelanotic Melanoma / M.Fujioka et al. / p463~463
  • General Lecture 250.Total Body Hyperthermotherapy(TBHT)for Malignant Melanoma / T.Karino et al. / p463~463
  • General Lecture 251.A Case of Malignant Pheochromocytoma (Paraganglioma) / T.Tabei et al. / p464~464
  • General Lecture 252.Hemostatic Abnormalities and Prognostic Evaluation in Leukemia / M.Tsuda et al. / p464~464
  • General Lecture 253.Not Received / /
  • General Lecture 254.Hemostatic Disorder in Hemotopoietic Malignancy--Coagulant and Fibrinolytic Activities in the Leukemic Cell Lysate / M.Tomeoku et al. / p465~465
  • General Lecture 255.Influence of PSK on the Proliferation and the Activation of Macrophage / Y.Hasegawa et al. / p465~465
  • General Lecture 256.Not Received / /
  • General Lecture 257.Leucocyte Migration Inhibition of Murine Spleen Cells after Immunization of Tumor Cells / T.Umeda et al. / p466~466
  • General Lecture 258.Transcatheter Electrocoagulation with Insulated Anode and Balloon Catheter / H.Kobayashi et al. / p466~466
  • General Lecture 259.Anti-tumor Effect of Tumor Treated with Microwave Tissue Coagulator / H.Noguchi et al. / p467~467
  • General Lecture 260.Transcatheter Arterial Embolization with Absolute Ethanol / N.Uchiyama et al. / p467~467
  • General Lecture 261.Thermochemotherapy for Gynecologic Malignancies--A Basic Study and Clinical Evaluation / I.Kohno et al. / p468~468
  • General Lecture 262.Experimental Studies of Hyperthermotherapy on Malignant Tumor / Y.Matsuzaki et al. / p468~468
  • General Lecture 263.Preliminary Study for the Result of the Chemotherapy against the Stomach Cancer,Using the Multiple Coefficient Analysis / S.Matano et al. / p469~469
  • General Lecture 264.Lymph Node,Portal Vein,Hepatic and Serum Levels after Intraluminal,Intrasubserosal,Intravenous and Intraarterial(Local)Injection of Carboquone(CQ)in the Dog and the Patients with Colo-rectal Cancer / A.Yagita et al. / p469~469
  • General Lecture 265.Regression of Advanced Gastric Cancer with MFC / T.Aonuma et al. / p470~470
  • General Lecture 266.The Effects of Short Term,High-dose 5-fluorouracil Therapy Supported with Intravenous Hyperalimentation for Extensive or Recurrent Cancer / M.Kimoto et al. / p470~470
  • General Lecture 267.Intratumoral Anticancer Chemotherapy by Ultrasonically Guided Puncture / M.Ryu et al. / p471~471
  • General Lecture 268.The Clinical Application of Continuous Hyperthermic Peritoneal Perfusion(CHPP)for Peritoneal Dissemination of Gastric Cancer / R.Hamazoe et al. / p471~471
  • General Lecture 269.Experimental Study of Hyperthermia--Newly Devised Microwave Antenna / H.Kai et al. / p472~472
  • General Lecture 270.Immunological Significance of Plasma Exchange in Cancer Patients / S.Matsumoto et al. / p472~472
  • General Lecture 271.Not Received / /
  • General Lecture 272.Studies on Effect of Intestinal Microflora on DMH-induced Cancer / M.Ogawa et al. / p473~473
  • General Lecture 273.Evaluation of Serum and Intratissular CoQ₁₀ Level in the Gastric Cancer / H.Kanbara et al. / p473~473
  • General Lecture 274.Analysis of Serum Cholesterol Levels in Gastrointestinal Cancer Patients in Japan by Case-control Study / Y.Uehara et al. / p474~474
  • General Lecture 275.The Hepatic Function after Intra-operative Arterial Infusion of ADRIAMYCIN in Gastric Cancer / O.Izuno et al. / p474~474
  • General Lecture 276.A New Therapy for Advanced Gastric Carcinoma by Arterial Infusion Chemotherapy with Angiotensin II / T.Konishi et al. / p475~475
  • General Lecture 277.Influence of HLBI(Human Lymphoblast Interferon) on the Treatment of Gastric Cancer by Endoscopic Injection,of Hepatoma and Cholangioma by Arterial Infusion, and of Metastatic Liver Tumor by Continuous Cannulation to the Hepatic Artery / Y.Kubota et al. / p475~475
  • General Lecture 278.A Trial for the Treatment of the Patient with Liver Metastasis from Colorectal Cancer / Y.Takata et al. / p476~476
  • General Lecture 279.Prognostic Evaluation of Rectal Cancer Following the Intra-arterial One Shot Administration of Mitomycin C / K.Hayashida et al. / p476~476
  • General Lecture 280.A Method to Retain Subcutaneously the Catheter End Connected to a New Silicone Reservoir in Intraarterial Infusion Chemotherapy / Y.Arai et al. / p477~477
  • General Lecture 281.Intraarterial Infusion Therapy for far Advanced Cancer Patients / Y.Kiyasu et al. / p477~477
  • General Lecture 282.The Influence of Vasoactive Agents on Intra-arterial Infusion of Chemotherapeutic Drug / Y.Seo et al. / p478~478
  • General Lecture 283.Evaluation of Intermittent Hepatic Arterial Occlusion with Infusion Chemotherapy for Unresectable Liver Cancer / M.Nakagawa et al. / p478~478
  • General Lecture 284.Clinical and Basic Studies on Preoperative Abdominal Arterial Infusion of Anticancer Agents / T.Suwa et al. / p479~479
  • General Lecture 285.Selective Intraarterial Injection of Large Doses Mitomycin C with Rapid Removal by Direct Hemoperfusion (DHP) / R.Suzuki et al. / p479~479
  • General Lecture 286.Intraarterial Infusion Therapy of Cisplatin(CDDP)in Unresectable Hepatocellular Carcinoma / T.Ichida et al. / p480~480
  • General Lecture 287.Hepatic Arterial Chemotherapy Using a Totally Implanted Drug Delivery System "Infusaid 210" for 2 Patients / T.Miura et al. / p480~480
  • General Lecture 288.Preoparative OMF Treatment for Gastric Cancer--Examination of Macroscopical Effect in Comparison with Histological Effect / M.Mukai et al. / p481~481
  • General Lecture 289.The Effectiveness of Preoperative Irradiation and Histological Diagnosis in Cancer of the Proximal Stomach and Esophageal Junction / H.Jyoko et al. / p481~481
  • General Lecture 290.Combined Treatment with Chemotherapy and Radiotherapy for Unresectable Gastric Cancer / K.Nakajima et al. / p482~482
  • General Lecture 291.Long Term Postoperative Adjuvant Chemotherapy for Gastric and Colo-rectal Carcinoma / K.Kunitomo et al. / p482~482
  • General Lecture 292.Treatment for Intrahepatic Recurrence of Operated Gastric Cancer / H.Kimura et al. / p483~483
  • General Lecture 293. Effect of Preoperative Administration of Adriamycin to Esophageal Cancer / T.Kabuto et al. / p483~483
  • General Lecture 294.Cis-diammine Dichloro Platinum(II)(CDDP)and Bleomycin in Esophageal and Head and Neck Cancer / T.Sasaki et al. / p484~484
  • General Lecture 295.Not Received / /
  • General Lecture 296.The Significance of the Preoperative Radiotherapy for Esophageal Cancer from the Points of View of Histological Effect and Prognosis / I.Ohashi et al. / p484~484
  • General Lecture 298.Significans of Preoperative Radiotherapy / T.Kondo et al. / p485~485
  • General Lecture 299.Radiotherapy of Primary Brain Tumor / A.Sugiyama et al. / p485~485
  • General Lecture 300.Afterloading Technique for the Interstitial Irradiation of Reccurent Gliomas / K.Nomura et al. / p486~486
  • General Lecture 301.The Effect of Radiotherapy on Metastatic Brain Tumor / Y.Kodama et al. / p486~486
  • General Lecture 302.Evaluation of Total Paremental Nutrition & Combination Therapy for Progressed Cancer / M.Takahashi et al. / p487~487
  • General Lecture 303.Histologic Effects of Oral Tegafur and UFT Administration in Gastric Cancers / J.Fujimoto et al. / p487~487
  • General Lecture 304.The Pre-operative Treatment of the Stomach Cancer (Intra-arterial Chemotherapy with Noradrenalin) / T.Sato et al. / p488~488
  • General Lecture 305.5FU,Adriamcin and BCNU(FAB)Combination Chemotherapy for Advanced Gastric Cancer / T.Sasai et al. / p488~488
  • General Lecture 306.Criteria for the Assessment of Chemotherapy of Borrmann Type 4 Gastric Cancer(2) / M.Kurihara et al. / p489~489
  • General Lecture 307.Chemotherapy of Gastric Cancer with Special Reference to Borrmann Type 4 Diffuse Carcinoma / Y.Yoshida et al. / p489~489
  • General Lecture 308.Study on the MFVC-OK Therapy against Inoperable Gastric Cancer Especially with Poorly Type / Y.Sakata et al. / p490~490
  • General Lecture 309.Effects of Combined Splenectomy and Immunochemotherapy in the Patients of Advanced Gastric Cancer / K.Naito et al. / p490~490
  • General Lecture 310.Immune Responsiveness of Postoperative Gastric Cancer Patients as Related to Anticancer Medication / K.Ishiyama et al. / p491~491
  • General Lecture 311.NK-activity and Its Changes of Pre-and Post-operative Course on Resectable Gastric Cancer Patients Mainly the Effect of Pre- and Post-operative Administration of OK-432 Evaluated by NK-activity / H.Oshita et al. / p491~491
  • General Lecture 312.Clinical Analysis on the Out-patient Treated with Long-term Oral Administration of Anti-cancer Drug / S.Soejima et al. / p492~492
  • General Lecture 313.A Study of Immunochemotherapy in Patients with Excision of Gastric Cancer / M.Nakagawa et al. / p492~492
  • General Lecture 314.Three-year Survival of Gastric Cancer Patients Treated with Postoperative Adjuvant Immunochemotherapy / S.Saji et al. / p493~493
  • General Lecture 315.Co-operative Study on Surgical Adjuvant Immunochemotherapy of Cancer,Especially on a Controlled Study of Gastric Cancer Treated by Long-term Immunochemotherapy after Curative Gastric Resection / M.Imaizumi et al. / p493~493
  • General Lecture 316.Cooperative Study on Chemotherapy for Advanced Gastric Cancer (First Report) -Controlled Study on AF and MF / K.Irie et al. / p494~494
  • General Lecture 317.Chemotherapy of the Advanced Gastric Cancer / T.Kimura et al. / p494~494
  • General Lecture 318.Randomized Study on the Long-term Adjuvant Chemotherapy with Futraful and Mitomycin C for Gastric Cancer: Second Study (A Second Report) / O.Abe et al. / p495~495
  • General Lecture 319.Protocol Studies of Surgical Adjuvant Immunochemotherapy for Gastric Cancer / K.Kumai et al. / p495~495
  • General Lecture 320.The Effects of Adjuvant Chemotherapy on the Mode Recurrence of Gastric Cancer / T.Takahashi et al. / p496~496
  • General Lecture 321.Direct Coronal Computed Tomography of the Pelvis and the Retroperitoneal Space / T.Umeyama et al. / p496~496
  • General Lecture 322.Significance and Usefulness of CT in Diagnostic Evaluation of Rectal Cancer / T.Sekine et al. / p497~497
  • General Lecture 323.Computed Tomography Detection of Lymph-nodes Metastasis in the Preoperative and Postoperative Evaluation of Cervical Cancer / K.Oohara et al. / p497~497
  • General Lecture 324.Prognostic Value of Lymphography in Cervical Cancer / H.Takahashi et al. / p498~498
  • General Lecture 325.Pre-operative Evaluation of the Intramuscular Invasion of the Endometrial Carcinoma by Selective Angiography and CT-scanning / H.Hata et al. / p498~498
  • General Lecture 326.Analysis of Ovarian Tumors Using CT Scanning / K.Itoh et al. / p499~499
  • General Lecture 327.Computed Tomographic Evaluation of Breast Carcinoma / K.Kanasugi et al. / p499~499
  • General Lecture 328.Studies on Uptake of ⁹⁹mTc-phosphate Compounds in Breast Cancer / M.Yamato et al. / p500~500
  • General Lecture 329.Studies on Bone Scintigram of Breast Cancer / H.Sonoo et al. / p500~500
  • General Lecture 330.Slice Image Analysis of Bone Scintigraphy in Evaluation of Osseous Metastasis of Prostatic Cancer / Y.Hirao et al. / p501~501
  • General Lecture 331.Ultrasonographic Classification of Bladder Cancer and Microscopically Evaluated Effect of Preoperative Treatment / M.Niizuma et al. / p501~501
  • General Lecture 332.⁹⁹mTechnetium Methylen Diphosphonate Scintigram in Neuroblastoma / T.Arai et al. / p502~502
  • General Lecture 333.rCBF in the Brain Tumors Measured by Xenon Enhanced CT / O. Nakamura et al. / p502~502
  • General Lecture 334.CT of Hypopharyngeal Cancer or Cervical Esophageal Cancer / T.Kato et al. / p503~503
  • General Lecture 335.Clinical Review of Malignant Major Salivary Gland Tumor / S.Haraguchi et al. / p503~503
  • General Lecture 336.Diagnosis of Liver Metastasis in Patients with Gastric Cancer: Reliability in Various Laboratory and Radiological Tests Including 5'-NPD V(5'Nucleotide Phosphodiesterase Isozyme V)Assay and Intraoperative Ultrasonography / H.Kenmizaki et al. / p504~504
  • General Lecture 337.Detection and Clinical Significance of Tumor Thrombi in the Portal Vein Demonstrated by Angiography in Patients with Hepatocellular Carcinoma / M.Kumagai et al. / p504~504
  • General Lecture 338.Angiographic,Microangiographic and Histopathologic Studies on Cancers of the Urinary Bladder / T.Dokiya et al. / p505~505
  • General Lecture 339.Surgical Treatment for Malignant Thymoma / H.Ayabe et al. / p505~505
  • General Lecture 340.Clinical Evaluation for Combined Thoracic Wall Resection in Lung Cancer / K.Shibata et al. / p506~506
  • General Lecture 341.Radiotherapy for Primary Lung Cancer / Y.Nakada et al. / p506~506
  • General Lecture 342.Postoperative Prognosis of 63 Lung Cancer Patients with Mediastinal Lymph Node Metastases / S.Fukai et al. / p507~507
  • General Lecture 343.Change in Pulmonary Functions after the Resection on Lung Cancer / I.Takagi et al. / p507~507
  • General Lecture 344.Clinical Evaluation of Domperidone Injection against Nausea and Epigastral Discomfort in Radiation Sickness / M.Endoh et al. / p508~508
  • General Lecture 345.Postoperative Intraluminal Radiotherapy with 137-Cs Tube for Carcinoma of the Bile Duct at the Liver Hilus / H.Ito et al. / p508~508
  • General Lecture 346.Radiotherapy for Carcinoma of the Bifurcation of the Hepatic Ducts / I.Nakanishi et al. / p509~509
  • General Lecture 347.Internal Hepatic Radiotherapy for Prophylactic Cancer Therapy--Radiation Effects on Hepatic Metastasis / K.Tazawa et al. / p509~509
  • General Lecture 348.Fast Neutron Therapy for Cancer of the Pancreas and the Bile Duct / Y.Ogata et al. / p510~510
  • General Lecture 349.Radiation Therapy for Pancreatic Carcinoma / M.Matsui et al. / p510~510
  • General Lecture 350.Prognostic Factors for Survival in Patients with Unresectable Pancreatic Cancer / K.Nakano et al. / p511~511
  • General Lecture 351.Fast Neutron Therapy for Prostatic Cancer / M.Maruoka et al. / p511~511
  • General Lecture 352. Clinical Application of Misonidazole to the Preoperative Radiotherapy of Bladder Cancer / K.Ono et al. / p512~512
  • General Lecture 353.Early Effects of Preoperative Radiation Therapy for Invasive Bladder Cancer / S.Isaka et al. / p512~512
  • General Lecture 354.Clinical Studies of Preoperative Irradiation for Bladder Tumors / H.Kawano et al. / p513~513
  • General Lecture 355.A Study on Radiosensitivity of Bladder Tumor--Evaluation of Clinical Effect of Radiation upon Patients with Bladder Tumor / K.Ieda et al. / p513~513
  • General Lecture 356.Metastatic Processes and an Indication of Surgery and/or Radiation Therapy for Metastatic Lesions of Urothelial Tumors of the Bladder / H.Saitoh et al. / p514~514
  • General Lecture 357.Adriamycin Ointment for Treatment of Recurrent Carcinoma / M.Fukuda et al / p514~514
  • General Lecture 358.Augmentation of the Generation of Cell-Mediated Cytotoxic Response by Adriamycin / S.Arinaga et al. / p515~515
  • General Lecture 359.Studies on Controlled-release from 5Fu-PGA / M.Hirano et al. / p515~515
  • General Lecture 360.Fundamental and Clinical Studies on Depot-type Anticancer Drugs Containing Contrast Medium for X-ray Examination / T.Okawa et al. / p516~516
  • General Lecture 361.In vitro Sensitivity Test of Anti-neoplastic Agents and Their Enhancement by Cepharanthin / S.Sekiya et al. / p516~516
  • General Lecture 362.Effect of Chemotherapy on the Interstitial Tissue of Malignant Human Tumor Transplanted into Nude Mice with Reference to Micro Vessels / H.Kurihara et al. / p517~517
  • General Lecture 363.The Cell Kinetics in Immunochemotherapy Using Masked Anti-cancer Drugs--A Study Using Flow-cytometry / K.Oda et al. / p517~517
  • General Lecture 364.Study on Increased Activation of Futraful through Concomitant Use of Cytochrome-c(2nd Report) / S.Ishibashi et al. / p518~518
  • General Lecture 365.Growth of Human and Murine Tumors Transplanted into Nude Mice with Genetic Backgrounds of BALB/c,DDD, and ICR / F.Asanuma et al. / p518~518
  • General Lecture 366.Low Histamine Levels in Sera of Patients with Malignant Tumors / T.Motoki et al. / p519~519
  • General Lecture 367.Effect on Protein Turnover by Removing Malignant Tumor in Rats / I.Kawamura et al. / p519~519
  • General Lecture 368.Experimental Studies on Modulation of Antitumor Immunity by Administration of Levamisole--Preliminary Report / T.Takekoshi et al. / p520~520
  • General Lecture 369.Serological Response of Melanoma Patients Injected with Allogeneic Melanoma Cell Vaccine / H.Takeyama et al. / p520~520
  • General Lecture 370.A Murine Tumor Escaping from Immune Destruction by the Xenogeneic Host / J.Fujimoto et al. / p521~521
  • General Lecture 371.Immunotherapeutic Effect of Auto-transplanted Malignant Tumor after Freeze by Liquid Nitrogen / K.Tari et al. / p521~521
  • General Lecture 372.Experimental Study for Treatment of Peritonilis Carcinomatosa by Ultrasonic Radiation in Peritoneal Cavity / K.Bando et al. / p522~522
  • General Lecture 373.Immunological Analysis of Various Immunopotentiators in Spontaneously Hypertensive Rats(SHR)with Congenital T-cell Depression / N.Takeichi et al. / p522~522
  • General Lecture 374.Changes of Antitumor Effects in the Regional Lymph Nodes of Mice after Tumor Removal by the Administration of a Streptococcal Preparation OK-432 / H.Matsumoto et al. / p523~523
  • General Lecture 375.Significance of Intraperitoneal Administration of OK-432 for Treatment of Carcinomatous Ascites I. / S.Yamamoto et al. / p523~523
  • General Lecture 376.Not Received / /
  • General Lecture 377.The Statistical Analysis of Advanced Cancer Patients in Treatment with an Extract from Human Tubercle Bacilli (S.S.M.) -Report IV / K.Fujita et al. / p524~524
  • General Lecture 378.Not Received / /
  • General Lecture 379.A New Diagnostic Method by Serum for Cancer--New Tumor Marker TAG(Third Report) / H.Odajima et al. / p524~524
  • General Lecture 380.Study on the Assessment of Chemotherapeutic Effect by Cytologic Examinations / M.Ikeda et al. / p525~525
  • General Lecture 381.Concanavalin A Binding Micro-heterogeneity of Alpha-Fetoprotein: Diagnostic Value / Y.Tsuchida et al. / p525~525
  • General Lecture 382.Not Received / /
  • General Lecture 383.Clinicopathologic Study on Carcinoid of the Stomach / H.Ohigashi et al. / p526~526
  • General Lecture 384.Clinical Studies of Hepatocellular Carcinoma in the Aged / M.Abe et al. / p526~526
  • General Lecture 385.Studies on the Prognostic Factors of Hepatocellular Carcinoma by Multiple Regression Analysis (Especially in Association with the Therapy) / H.Hirose et al. / p527~527
  • General Lecture 386.Cytotoxic Effects of Anthracycline Antibiotics on Human Hepatoma in vitro / K.K ukita et al. / p527~527
  • General Lecture 387.Radical Operation for Carcinoma of the Gallbladder / T.Nagakawa et al. / p528~528
  • General Lecture 388.Mass Screening for Colorectal Cancer Using Fecal Occult Blood Testing The Seventh Report / M.Fujita et al. / p528~528
  • General Lecture 389.Clinical and Experimental Evaluation of Autosuture for Gastric Cardiac Cancer with Special Reference to Wound Healing and Anthropometric Parameter and Nutrionalstate / M.Kitajima et al. / p529~529
  • General Lecture 390.Relationship between the Size of Tumor and Depth of Wall Invasion in Gastric Cancer / N.Kaibara et al. / p529~529
  • General Lecture 391.Not Received / /
  • General Lecture 392.Not Received / /
  • General Lecture 393.A Study of Recurrent Cases after Curative Resection of Gastric Carcinoma / Y.Yamamoto et al. / p530~530
  • General Lecture 394.Evaluation of Pancreas-spleen Combined Resection Cases in the Gastric Cancer Invased to the Pancreas (S₃) / Y.Kawashima et al. / p530~530
  • General Lecture 395.The Role of the Ionization Constant in the Absorption of Drugs through the Bladder Epithelium / M.Nakao et al. / p531~531
  • General Lecture 396.Antiemetic Effect of Droperidol Continuous Drip Infusion / T.Tanahashi et al. / p531~531
  • General Lecture 397.Experience of Arterial Infusion Therapy for Local Recurrence and Liver Metastasis of Pelvi-Ureteric Tumor / M.Sahashi et al. / p532~532
  • General Lecture 398.Clinical Study of Urethral Cancer at Okayama University (OUCCG) / Y.Nasu et al. / p532~532
  • General Lecture 399.Continuous Infusion of Peplomycin Subcutaneously in Advanced Penile Cancer: A Case Report / T.Obama et al. / p533~533
  • General Lecture 400.Tumor Growth Inhibition by Nd-YAG LASER or Argon LASER against Rat Transplantable Tumor (R9061) / N.Yamamoto et al. / p533~533
  • General Lecture 401.Renin-producing Transitional Cell Carcinoma of Bladder / M.Kurosawa et al. / p534~534
  • General Lecture 402.Detection of Tumor-associated Antigen in Urine from Bladder Cancer Patients / M.Kawamura et al. / p534~534
  • General Lecture 403.Implant Operation of Penile Prosthesis in Erectile Impotence Patients Received Intrapelvic Cancer Surgery / T.Fujioka et al. / p535~535
  • General Lecture 404.Experimental Study in Lung and Mediastinal Lymph Flows--Preventive Method against Metastasis to the Mediastinal Lymph Nodes of the Opposite Side / T.Arimura et al. / p535~535
  • General Lecture 405.Comparative Studies on NK Activity and Cytotoxic Activity against Cultured Human Lung Cancer Cells by in vitro Activated Autologous Lymphocytes / H.Kimura et al. / p536~536
  • General Lecture 406.Effect of Platelet Aggregating Inhibitors on Blood Borne Metastasis / T.Ishii et al. / p536~536
  • General Lecture 407.Clinical Application of Arterial Embolization Therapy Using Absolute Ethanol / S.Onohara et al. / p537~537
  • General Lecture 408.Comparison of Prognosis between Operation Alone and Operation with Adjuvant Therapy for Epidermoid Cancer Patients with Lung Cancer--Results of Field Study in Japan--Report from the Japan Lung Cancer TNM Classification Committee / K.Yoshimura et al. / p537~537
  • General Lecture 409.Effect of Adjuvant Therapy on the Operated Cases with Squamous Cell Carcinoma of the Lung / K.Kunishima et al. / p538~538
  • General Lecture 410.Radiotherapy for Inoperable Squamous Cell Lung Cancers / M.Kawahara et al. / p538~538
  • General Lecture 411.Evaluation of Radiotherapy Alone for Epidermoid Carcinoma of the Lung / M.Kimura et al. / p539~539
  • General Lecture 412.Concervative Treatment for Superficial Penile Cancer: Comparison of Electron Therapy to Radiotherapy Combined with Simultaneous Bleomycin / N.Abe et al. / p539~539
  • General Lecture 413.Modification of Muscle-preserving Radical Mastectomy / H.Kodama / p540~540
  • General Lecture 414.Reconstruction of Surgical Defects of Chest Wall for Breast Cancer / S.Hirao et al. / p540~540
  • General Lecture 415.Reconstruction of Hypopharynx and Cervical Esophagus Using Free Jejunal Graft / S.Takeoda et al. / p541~541
  • General Lecture 416.Use of a Long Skin Tube of the Anterior Chest for Esophageal Bypass / I.Honda et al. / p541~541
  • General Lecture 417.New Prosthetic Reconstruction of the Trachea and Carina / M.Kuwabara et al. / p542~542
  • General Lecture 418.Study on Absorption of Oral 5-FU(II)Oral 5-FU Emulsion (FUE) / T.Kamano et al. / p542~542
  • General Lecture 419.Serum and Tissue Concentration of 5-FU Derivative(THFU)after Oral Administration / T.Ohno et al. / p543~543
  • General Lecture 420.Clinical and Pathological Evaluation of Preoperative Gastric Cancer Adjuvant Chemotherapy with TEGAFUR(FT-207)Suppository and GLUTATHIONE / F.Kaga et al. / p543~543
  • General Lecture 421.Distribution of Tegafur Enteric Granule in Cancer Patients / S.Arima et al. / p544~544
  • General Lecture 422.Conversion of Tegaful to 5 FU in 422 Cancer Tissues / Y.Hirayama et al. / p544~544
  • General Lecture 423.Practice and Histological Study of the Continuous Infusion of Tegaful / A.Yagawa et al. / p545~545
  • General Lecture 424.Clinical Evaluation of Chemoimmunotherapy for Advanced Gastrointestinal Cancer / K.Takahashi et al. / p545~545
  • General Lecture 425.Immunochemotherapy for Gastric Cancer after Surgical Treatment / H.Yagawa et al. / p546~546
  • General Lecture 426.Not Received / /
  • General Lecture 427.Intravenous Administration of OK-432 to the Gastric,Colon and Rectal Cancer Patients with Non-curative Resections and Its Effect to the Survival / A.Kawamura et al. / p546~546
  • General Lecture 428.Chemotherapy for Stomach Cancer by Endoscopic Injection of Methyl-CCNU in Emulsion / H.Mizusawa et al. / p547~547
  • General Lecture 429.Regional Lymphatic System Distribution of Orally Administered 5-FU Emulsion in Gastric Cancer Patients / M.Fujita et al. / p547~547
  • General Lecture 430.Combined Chemo-and Radiation Therapy of Esophagus Cancer,Using Vindesine as Anticancer Agent / S.Suga et al. / p548~548
  • General Lecture 431.Tγ Cells and Its Changes by Irradiation in Patients with Esophageal Carcinoma / T.Fukuda et al. / p548~548
  • General Lecture 432.Studies as to the Immunological Variation Due to the Treatment of the Esophageal Carcinoma: The Influence by the Pre-operative Irradiation and Operative Stress / Y.Nakata et al. / p549~549
  • General Lecture 433.Analysis of the Relation between Serum Albumin and NK Cell Activity in the Patients with Cancer / K.Tsuji et al. / p549~549
  • General Lecture 434.Combination Chemotherapy,Comparison of Mitomycin C: 5-fluorouracil Treatment Versus Mitomycin C:5-fluorouracil Plus OK 432(an Immunotherapy)-Effect on Immunological Parameters / H.Furue et al. / p550~550
  • General Lecture 435.Combined Therapy in Non-resectable Esophageal Carcinoma with Particular Regard to Injection of PANa-oil Bleomycin / Y.Katabe et al. / p550~550
  • General Lecture 436.The Analysis of Five Year Survival Cases with Metastatic Lymphnodes in Carcinoma of the Esophagus / H.Watanabe et al. / p551~551
  • General Lecture 437.Prognosis of the Thoracic Esophageal Carcinoma with Special Reference to the Number of the Metastatic Lymph Nodes and Their Metastatic Portion / N.Omori et al. / p551~551
  • General Lecture 438.The Effect of Post-operative Radiation Therapy for Esophagus Cancer / M.Yoshimoto et al. / p552~552
  • General Lecture 439.Study on the Thoracic Esophageal Cancer Patients with Palliative Resection of the Primary Lesion / M.Hirayama et al. / p552~552
  • General Lecture 440.Relationship between Pulmonaly Complications and Preoperative Factors of Esophageal Cancer / T.Hirai et al. / p553~553
  • General Lecture 441.Esophageal Cancer in Old-aged Patients--Especially Psychological Therapy / R.Amano et al. / p553~553
  • General Lecture 442.Surgical Treatment of Carcinoma of Gastro-esophageal Junction / M.Kawaguchi et al. / p554~554
  • General Lecture 443.A Study on Surgical Treatment of Upper Gastric Cancers / H.Suzuki et al. / p554~554
  • General Lecture 444.Retrospective Studies of Operation Methods on the Upper Gastric Cancer / H.Fukushima et al. / p555~555
  • General Lecture 445.Proposal of Concept of"Minute Gastric Cancer" / H.Kitaoka et al. / p555~555
  • General Lecture 446.A Clinicopathological Study on Early Gastric Cancer with Submucosal Involvement / Y.Miyamoto et al. / p556~556
  • General Lecture 447.A Study of Pm Cancer / A.Misao et al. / p556~556
  • General Lecture 448.Histologic Type and Hepatic Metastasis in Gastric Carcinoma with Special Reference to Poorly Differentiated Adenocarcinoma with Medullary Growth / O.Kimura et al. / p557~557
  • General Lecture 449.Morphological and Histochemical Studies on the Relationship between the Mucous-producing Cancer Cells and Interstinum in the Gastric Cancer of Borrmann's Type 4 / Y.Kato et al. / p557~557
  • General Lecture 450.Surgical Treatment for Borrmann IV Gastric Cancer / T.Ishii et al. / p558~558
  • General Lecture 451.Evaluation of Survival Ratios in Gastric Cancer Patients with or without Splenectomy in Total Gastrectomy / M.Danno et al. / p558~558
  • General Lecture 452.Surgical Result of Total Gastrectomy for Cancer of the Stomach / M.Okazaki et al. / p559~559
  • General Lecture 453.Studies on the Therapy of the Recurrence Gastric Cancer / A.Gochi et al. / p559~559
  • General Lecture 454.A Clinicopathological Analysis of Gastric Carcinoma in the Old / Y.Kato et al. / p560~560
  • General Lecture 455.Treatment Result of Malignant Smooth Muscle Tumors of the Stomach,Special Reference to Indication of Local Excision for Tumors / H.Kitaoka et al. / p560~560
  • General Lecture 456.Lymphatics in Lamina Propria Mucosae of Colon / T.Hirashima et al. / p561~561
  • General Lecture 457.Analysis on Synchronous and Metachronous Double Carcinomas Associated with Esophageal Carcinoma / K.Tajima et al. / p561~561
  • General Lecture 458.Multiple Primary Cancers Associated with Primary Large Intestinal Cancer / A.Ouchi et al. / p562~562
  • General Lecture 459.Chemotherapy of Hepatic Metastases from Colorectal Cancers / T.Kato et al. / p562~562
  • General Lecture 460.Hepatocellular Carcinoma with Bile Duct Invasion / S.Itoh et al. / p563~563
  • General Lecture 461.Stage Classification and Surgical Treatment of Bile Duct Carcinoma / T.Tsunoda et al. / p563~563
  • General Lecture 462.The Postoperative Follow-up Study in Carcinoma of Gallbladder and Extrahepatic Biliary Tract Treated by Immunochemotherapy / Y.Suda et al. / p564~564
  • General Lecture 463.Chemotherapy in Gallbladder Carcinoma and Bile Duct Carcinoma / T.Izumi et al. / p564~564
  • General Lecture 464.Determination of Endogenous Estrogen Hormone in Tissues of Pancreatic and Choledochal Cancers / Y.Marugami et al. / p565~565
  • General Lecture 465.Chemotherapy for the Irresectable Carcinoma of the Periampulla and Pancreas / Y.Matsui et al. / p565~565
  • General Lecture 466.Clinical and Statistical Study of Tongue Cancers Concerning NO Patients / Y.Utsunomiya et al. / p566~566
  • General Lecture 467.Autopsy Findings in 20 Cases of Tongue Cancer / S.Matsuura et al. / p566~566
  • General Lecture 468.Some Remarks on the Treatment Techniques and Indication of Electron Beam Therapy for the Oral Cavity / K.Iida et al. / p567~567
  • General Lecture 469.Radiation Therapy of Laryngeal Cancers in Our Department / E.Takenaka et al. / p567~567
  • General Lecture 470.A Study of the Cervical Lymphnode Metastasis of Tongue Cancer on Which Interstitial Radio-therapy Has Been Performed / Y.Honke et al. / p568~568
  • General Lecture 471.On the Relation between the Distribution of Cervical Lymph Node Metastases from Cancer of the Oral Cavity and the Prognoses / T.Tachibana et al. / p568~568
  • General Lecture 472.Treatment Results of Patients with Carcinoma of Oral Cavity by Radiotherapy Combined with Bleomycin / N.Masaki et al. / p569~569
  • General Lecture 473.Investigation of Therapeutics for Cancer of the Tongue / T.Amagasa et al. / p569~569
  • General Lecture 474.Surgical Treatment of Oral Cancer Classified in T3 or T4 / J.Kato et al. / p570~570
  • General Lecture 475.Malignant Neoplasm of the Nasopharynx / T.Yanagita / p570~570
  • General Lecture 476.Combined Therapy in Recurrent and Extended Metastatic NPC / S.Lian et al. / p571~571
  • General Lecture 477.Not Received / /
  • General Lecture 478.The Borderline Cases between the Laryngeal and Hypopharyngeal Cancers / H.Miyahara et al. / p571~571
  • General Lecture 479.Long Term Results of Treatment of the Larynx on Chemo-radiotherapy (FAR Therapy) / S.Komiyama et al. / p572~572
  • General Lecture 480.Radiation Therapy of Lingual Cancers in Our Department / E.Takenaka et al. / p572~572
  • General Lecture 481.Tumor Response and Local Control after Radiotherapy of TINOMO Glottic Carcinoma / T.Inoue et al. / p573~573
  • General Lecture 482.Radiotherapy for Early Glottic Cancer / Y.Kagami et al. / p573~573
  • General Lecture 483.Evaluation of Treatment by a Single Modality for Head and Neck Malignancies / S.Horiguchi et al. / p574~574
  • General Lecture 484.Clinical Usefulness of Computed Tomography in Thyroid Carcinoma Infiltrating the Trachea / K.Kikuchi et al. / p574~574
  • General Lecture 485.Clinicopathological Studies on Thyroid Cancer Diagnosed from Metastatic Cervical Lymph Nodes / H.Soga et al. / p575~575
  • General Lecture 486.A Mass Screening for the Thyroid Cancer in Gunma Prefecture / K.Inoue et al. / p575~575
  • General Lecture 487.Mass Screening for the Thyroid Cancer / M.Noguchi et al. / p576~576
  • General Lecture 488.The Effect of I-131 Therapy in the Management of Distant Metastases of Thyroid Cancer / K.Kusakabe et al. / p576~576
  • General Lecture 489.Treatment for the Esophagus Infiltrated with Thyroid Cancer / Y.Nomura et al. / p577~577
  • General Lecture 490.Results of the Conservative Therapy of Bilateral Retinoblastoma Followed More Than 5 Years / A.Kaneko / p577~577
  • General Lecture 491.Growth Rate of Retinoblastoma / S.Totsuka et al. / p578~578
  • General Lecture 492.Primary Malignant Lymphoma of the Thyroid--An Experience of 4 Cases / K.Omura et al. / p578~578
  • General Lecture 493.Surgical Treatment of Recurrent Parathyroid Carcinoma / T.Obara et al. / p579~579
  • General Lecture 494.Combined Treatment of Carcinoma of the Maxillary Sinus / M.Morita et al. / p579~579
  • General Lecture 495.Multimodal Therapy for T4 Maxillary Antrum Cancer / T.Teshima et al. / p580~580
  • General Lecture 496.A Study of 103 Cases of Non-palpable Breast Carcinoma / K.Okamoto et al. / p580~580
  • General Lecture 497.Estimation of the"No",Cases of the Breast Cancer / H.Yokoyama et al. / p581~581
  • General Lecture 498.Necessity of Removal of Parasternal Lymphnodes in Radical Operation of the Breast Cancer / T.Sekimoto et al. / p581~581
  • General Lecture 499.Pectoral Nerve Preserving Operation for Breast Cancer in the Patey's Method--Its Morphological and Functional Effects against Major Pectoral Muscle / S.Nakatani et al. / p582~582
  • General Lecture 500.Extened Resection of Advanced Cancer with Skin Reconstruction / M.Nakahara et al. / p582~582
  • General Lecture 501.Not Received / /
  • General Lecture 502.Not Received / /
  • General Lecture 503.Oral High-dose Medroxyprogesterone Acetate(MAP)Therapy in Advanced and Recurrent Breast Cancer (Phase I Clinical Trial) Research Group of MAP Treatment for Breast Cancer in Japan / Y.Iino et al. / p583~583
  • General Lecture 504.High Dose Chemotherapy with Autologous Bone Marrow Transplantation in Advanced Breast Carcinoma / T.Tajima et al. / p583~583
  • General Lecture 505.High-dose Methotrexate with CF Rescue for Recurrent Breast Cancer / A.Nakano et al. / p584~584
  • General Lecture 506.Chemo-endocrine Therapy with Tamoxifen,Tegafur and Cyclophosphamide in a Treatment of Advanced Breast Cancer / T.Wada et al. / p584~584
  • General Lecture 507.The Use of Aminoglutethimid in Treatment of Breast Cancer / M.Imura et al. / p585~585
  • General Lecture 508.Mass Screening of Breast Carcinoma in Miyagi Prefecture / R.Abe et al. / p585~585
  • General Lecture 509.The Analysis of Mass Screening for the Breast Cancer / T.Takahashi et al. / p586~586
  • General Lecture 510.The Breast Cancer Screening Survey in Kanagawa Prefecture(The Third Report) / T.Suda et al. / p586~586
  • General Lecture 511.The Results of Mass Examination of Breast Carcinoma in Yokohama City / H.Takemura et al. / p587~587
  • General Lecture 512.Mass Screening for Breast Cancer / K.Kuwata et al. / p587~587
  • General Lecture 513.Cis-Platinum in the Treatment of Esophageal Carcinoma / K. Yoshida et al. / p588~588
  • General Lecture 514.Evaluation of Cisplatin in Children with Malignant Solid Tumor / Y.Hayashi et al. / p588~588
  • General Lecture 515.Effect of the Combination of Cisplatin and Peplomycin--Fundamental and Clinical Study / S.Mashino et al. / p589~589
  • General Lecture 516.A Three-drug Combination Chemotherapy Consisting of Mitomycin C,Vincristine,and Cis-Diamminedichloroplatinum(II)(MVP)for Advanced Cervical Cancer / K.Ikeda et al. / p589~589
  • General Lecture 517.Assessment of Arterial Chemotherapeutic Effects in Patients with Hepatocellular Carcinoma: Altemate and Simultaneous Administration of Adriamycin and Mitomycin C / K.Hirai et al. / p590~590
  • General Lecture 518.Intra-arterial One Shot and Transcatheter Embolization Therapy in Hepatocellular Carcinoma / T.Nakanishi et al. / p590~590
  • General Lecture 519.An Investigation of Complications Occurring in Arterial Infusion Chemotherapy of Hepatoma / Y.Sasaki et al. / p591~591
  • General Lecture 520."Two Route Infusion Chemotherapy"of Cis-Diamminedichloroplatinum and Its Antidote,Sodium Thiosulfate,for Human Primary and Secondary Liver Cancer / R.Abe et al. / p591~591
  • General Lecture 521.Bile Duct Cancer Model by VX2 Carcinoma Transplantation in Rabbits,and Its Chemotherapy / K.Sakuraba et al. / p592~592
  • General Lecture 522.Experimental Study Concerning the Effects of Postoperative Adjuvant Chemotherapy on Hepatic Regeneration / H.Kohno et al. / p592~592
  • General Lecture 523.Treatment of Primary and Secondary Liver Cancer with EthiodolR Containing Lipophilic Anticancer Agent,SMANCS / T.Konno et al. / p593~593
  • General Lecture 524.Studies on the Selective Delivery of Anticancer Agent in Tumor Tissue: Evidences of Preferencial Accumulation of Lipophilic High Molecular Weight Antitumor Agent Smancs in Hepatoma / H.Maeda et al. / p593~593
  • General Lecture 525.Combination Chemotherapy for Inoperable Liver Cancer (Primary and Metastatic) -Study on MQ-F-OK Therapy Including the Intraarterial Administration of MMC and CQ / K.Tsushima et al. / p594~594
  • General Lecture 526.Clinical Application of Microencapsulated Anticancer Drugs / R.Abe et al. / p594~594
  • General Lecture 527.Intra-arterial Infusion of Micro-encapsulated Mitomycin C in the Treatment of Unresectable Hepatoma(2nd Report) / Y.Tsuji et al. / p595~595
  • General Lecture 528.Treatment of Unresectable Hepatocellular Carcinoma by Arterial Infusion of Mitomycin C Microcapsules (MMCmc) / S.Tsuchiya et al. / p595~595
  • General Lecture 529.Microcapsulated Mitomycin C Therapy in Unresectable Hepatoma and Liver Metastases of Miscellaneous Cancer (The Second Report) / J.Itoh et al. / p596~596
  • General Lecture 530.Intra-arterial Chemoembolization of Microencapsulated Mitomycin C in the Treatment of Advanced Carcinoma / H.Kurokawa et al. / p596~596
  • General Lecture 531.Enhancement Effect of Attainability of Mixed Miceli into the Cerebral Parenchyma / H.Nogaki et al. / p597~597
  • General Lecture 532.Comparative Pharmacokinetics of UFT and FT-207 on Human Malignant Brain Tumors / H.Okamoto et al. / p597~597
  • General Lecture 533.Chemotherapy of Recurrent Glioblastoma / Y.Ushio et al. / p598~598
  • General Lecture 534.High-dose Chemotherapy with Autologous Bone Marrow Transplantation for Malignant Brain Tumors / S.Shibui et al. / p598~598
  • General Lecture 535.Photodynamic Effects of Hematoporphyrin Derivatives(HpD)on SKG-1 Cells Cultivated in vitro / K.Kubota et al. / p599~599
  • General Lecture 536.The Use of Laser in Treating Cancer of the Oral Cavity / M.Hirano et al. / p599~599
  • General Lecture 537.Argon Dye Laser Photoradiation with Hematoporphyrin Derivative for Carcinoma of the Head and Neck / T.Hirokawa et al. / p600~600
  • General Lecture 538.Endoscopic Nd
  • YAG Laser Treatment of Early Gastric Cancer / M.Sasako et al. / p600~600
  • General Lecture 539.Histological and Biochemical Effects on Dog Liver by Experimental Hepatic Arterial Embolization / K.Hirai et al. / p601~601
  • General Lecture 540.Newly Developed Ferromicrocapsule as Embolic Material for the Treat of Malignant Tumors / S.Hirota et al. / p601~601
  • General Lecture 541.Ethanol Embolization of Renal Artery / M.Tachibana et al. / p602~602
  • General Lecture 542.Preoperative Selective Intra-arterial Infusion Chemotherapy for Rectal Cancer (The First Report) -On the Side Effects- / M.Kameyama et al. / p602~602
  • General Lecture 543.Pre-operative Transcatheter Arterial Embolization for the Patients with Locally Advanced Breast Cancers--A Newly Deviced Thrombotic Materials / Y.Takatsuka et al. / p603~603
  • General Lecture 544.Ferromagnetic Microembolization of Tumors: With Ferropolysaccharide and Opposed Two Field Electromagnet / M.Sako et al. / p603~603
  • General Lecture 545.Experimental Studies on Ferromagnetic Microembolization in the Treatment of Metastatic Liver Tumors / H.Yuri et al. / p604~604
  • General Lecture 546.Not Received / /
  • General Lecture 547.Not Received / /
  • General Lecture 548.Multidisciplinary Treatment for Advanced Hepatamas / S.Higashi et al. / p604~604
  • General Lecture 549.Fundamental Studies of Hyperthermia--Blood Flow Changes in Localized Hyperthermia / T.Asano et al. / p605~605
  • General Lecture 550.Application of Hyperthermia to Treatment for Cervical Cancer / T.Kagabu et al. / p605~605
  • General Lecture 551.Hyperthermo-chemotherapy for Peritoneal Dissemination of Cancer by Peritoneal Perfusion / N.Mizuguchi et al. / p606~606
  • General Lecture 552.A Newer Hyperthermic Therapy with an Immunopotentiator (OK-432) / T.Nishida et al. / p606~606
  • General Lecture 553.Radiofrequency Hyperthermia of Monkey and Human Malignant Brain Tumors / R.Tanaka et al. / p607~607
  • General Lecture 554.Cell Growth Inhibition by Irradiation in Combination with Hyperthermia or Anticancer Drugs / H.Hisazumi et al. / p607~607
  • General Lecture 555.Combination of Cis-platinum with Extracorporeally Induced Total Body Hyperthermia / N.Yamanaka et al. / p608~608
  • General Lecture 556.Effects of Anticancer Drugs and Hyperthermia on Colony Growth of Cells from Malignant Effusions / T.Akiyoshi et al. / p608~608
  • General Lecture 557.Extracorporeal Circuit(ECC)of Total Body Hyperthermia(TBHT)for Cancer Treatment and Its Bodily Reaction / M.Maeta et al. / p609~609
  • General Lecture 558.Clinical Experience of Local Hyperthermia / T.Nakajima et al. / p609~609
  • General Lecture 559.System for Variable Target Irradiation for the Purpose of Minimizing Complication in Radiation Therapy / Y.Aoki et al. / p610~610
  • General Lecture 560.Experimental Study on Active Specific Immunotherapy Utilizing the Immune Reaction of Low-dose Irradiated Tumor Tissue / Y.Ogawa et al. / p610~610
  • General Lecture 561.Clinicopathological Features of Soft Tissue Tumors in the Abdomen / H.Ishikawa et al. / p611~611
  • General Lecture 562.Nine Patients with Post-radiation Sarcoma / S.Wada et al. / p611~611
  • General Lecture 563.Estimation of the Local Effects of Preoperative Radiotherapy in the Treatment of Malignant Soft Part Tumors / E.Hodaka et al. / p612~612
  • General Lecture 564.Radiotherapy of Malignant Fibrous Histiocytoma / J.Ito et al. / p612~612
  • General Lecture 565.Fundamental Experiences of Intraoperative Irradiation for Pediatric Malignant Solid Tumor / M.Yamamoto et al. / p613~613
  • General Lecture 566.The Role of Radiotherapy for Wilms' Tumor / M.Hareyama et al. / p613~613
  • General Lecture 567.Clinical Study and Therapeutic Modalities of Patients with Diffusely Infiltrative Bone Marrow Metastasis / K.Yokoyama et al. / p614~614
  • General Lecture 568.A Combination Chemotherapy with Adriamycin,Cyclophosphamide and DTIC in Soft Tissue Sarcomas / M.Domyo et al. / p614~614
  • General Lecture 569.Experimental Results of Methotrexate Tissue Concentration and Histological Changes after High-dose Methotrexate Infusion on Osteosarcoma / S.Yamawaki et al. / p615~615
  • General Lecture 570.The Experimental Study on the Suppressive Effect for Pulmonary Metastasis by the Arterialinfusion of Adriamycin / K.Suzuki et al. / p615~615
  • General Lecture 571.An Analysis of Pulmonary Metastatic Foci in the Clinical Course of Osteosarcoma / Y.Nishimoto et al. / p616~616
  • General Lecture 572.A Prolonged Survival Case of Parosteal Osteosarcoma--Multimodal Therapy / S.Shoji et al. / p616~616
  • General Lecture 573.Fluorometric Lymphocyte Blastformation Test--PHA / Y.Inui et al. / p617~617
  • General Lecture 574.Cryo-immunotherapy / S.Tomiyama et al. / p617~617
  • General Lecture 575.Clinical Studies on the Immunotherapy with Intradermal Injections of OK-432 / T.Kudo et al. / p618~618
  • General Lecture 576.Experimental Study on Autologous Graft of Lymph Node(3) / H.Hosohata et al. / p618~618
  • General Lecture 577.Not Received / /
  • General Lecture 579.Fine Needle Aspiration Cytology in Diagnosis of Breast Lesions / S.Tajima et al. / p619~619
  • General Lecture 580.Determination of Residual Foci in the Uterus after Conization / Y.Sakaguchi et al. / p619~619
  • General Lecture 581.Histopathological Classification of Uterine Choriocarcinoma / Y.Nishikawa et al. / p620~620
  • General Lecture 582.Sarcoma of the Uterus (A Clinical and Pathologic Study of 22 Cases) / M.Imachi et al. / p620~620
  • General Lecture 583.Diagnostic Value of Biochemical Tumor Markers in Serum,Ultrasonography and Papanicolaou Smear in Ascites for Human Malignant Tumor of the Ovary / I.Kizawa et al. / p621~621
  • General Lecture 584.Biochemical Changes in Ascitic Fluid in Ovarian Malignancy / M.Yoshioka et al. / p621~621
  • General Lecture 585.Not Received / /
  • General Lecture 586.Preliminary Report on the Use of Adriamycin and Methotrexate in Squamous Cell Carcinoma of the Uterine Cervix / K.Tamai et al. / p622~622
  • General Lecture 587.Analyses about the Improvement of Local Control Rate on Irradiated Carcinoma of the Cervix Uteri / T.Arai et al. / p622~622
  • General Lecture 588.Usefulness of Serial CEA Determinations in Follow-up during Radiotherapy for Squamous Cell Carcinoma of the Cervix / K.Hasumi et al. / p623~623
  • General Lecture 589.Clinical Studies Concerning the Combined Use of Kallidinogenase in Cancer Chemotherapy / Y.Kawai et al. / p623~623
  • General Lecture 590.Pharmacokinetics of the FT-207 Rectal Suppository against Squamous Cell Carcinoma of the Uterine Cervix(Second Report) / H.Okazaki et al. / p624~624
  • General Lecture 591.Surgical Treatment for Intestinal Complication after Radio-and/or Operative Therapy of the Uterine Cervical Cancer / K.Ueda et al. / p624~624
  • General Lecture 592.Treatment of the Invasive Vulvar Cancer / T.Kaiho et al. / p625~625
  • General Lecture 593.The Problems of Operative Methods for Ovarian Malignancies / H.Nishimura et al. / p625~625
  • General Lecture 594.The Reoperation against Recurrence of Colorectal Cancer / T.Mori et al. / p626~626
  • General Lecture 595.Three Cases of Total Residual Pelvic Exenteration Combined with Sacral Resection for Locally Recurrent Rectal Cancer / H.Takagi et al. / p626~626
  • General Lecture 596.Analysis of the Prognosis in Patients with Rectal Cancer. Results of 260 Consecutive Curative Operations / K.Furushima et al. / p627~627
  • General Lecture 597.Effective Protection with Combination of Domperidone and Moderate-dose of Glucocorticoid against Cis-DDP Induced Emesis / M.Murakami et al. / p627~627
  • General Lecture 598.Clinical Evaluation of Nauzelin as an Antiemetic in Cancer Patients Receiving Radiotherapy and Chemotherapy / K.Sekiguchi et al. / p628~628
  • General Lecture 599.Domperidone(Anuselin)in the Prophylactic Treatment of Emesis Induced by Cancer Chemotherapeutic Agents / H.Majima / p628~628
  • General Lecture 600.Gastrointestinal Hemorrhage during Cancer Chemotherapy / H.Nasu et al. / p629~629
  • General Lecture 601.Studies on Chronic Disseminated Intravascular Coagulation in Patients with Terminal Cancer / K.Bessho et al. / p629~629
  • General Lecture 602.Amino Acid Imbalance by TPN as an Adjunct to Cancer Therapy / N.Goseki et al. / p630~630
  • General Lecture 603.Colony Formation of Various Malignancies in Human Tumor Stem Cell Assay / T.Kobayashi et al. / p630~630
  • General Lecture 604.Multi-disciplinary Cancer Treatment Including Total-body Hyperthermia Combined with Plasmapheresis / M.Hosoi et al. / p631~631
  • General Lecture 605.Not Received / /
  • General Lecture 606.Timing of the Administration of Drugs in Immunochemotherapy / K.Nakamura et al. / p631~631
  • General Lecture 607.Results of Combined Treatment of Irradiation,Immunotherapy,and Antitumor Agents against Malignant Tumors,and the Transition of Immunological Capacity / K.Tamura et al. / p632~632
  • General Lecture 608.Clinical Evaluation of Combination Therapy of Localized Hyperthermia by Microwaves and Chemotherapy for Far-advanced Carcinomas / T.Saito et al. / p632~632
  • General Lecture 609.Immunochemotherapy of Established Experimental Brain Tumors with ACNU and C.Parvum / Y.Kida et al. / p633~633
  • General Lecture 610.Application of Perfluorochemicals to Cancer Chemotherapy--Effect to the Rat Brain Tumor Model / T.Kokunai et al. / p633~633
  • General Lecture 611.Three Dimensional Moving Field Radiation Therapy--Physical and Biological Estimation of Its Usefulness / S.Koga et al. / p634~634
  • General Lecture 612.Quantitative Measurement of CSF Polyamines by Thin Layer Chromatography / F.Nakajima et al. / p634~634
  • General Lecture 613.Immuno-suppressive T Lymphocytes in Patients with Malignant Brain Tumors / S.Yoshida et al. / p635~635
  • General Lecture 614.Immunological Studies with Surgery and Radio-immuno-chemotherapy for Brain Tumors / K.Kawamoto et al. / p635~635
  • General Lecture 615.Treatment of Brain Tumor and Inducement of Interferon with Lymphocytes Sensitized by Tumor-immune RNA / K.Saito et al. / p636~636
  • General Lecture 616.Effect of UFT in Malignant Glioma (Part 2) -Concentration of 5-FU in Human Brain Tumors- / H.Nogaki et al. / p636~636
  • General Lecture 617.Experimental Chemotherapy of Human Breast Carcinomas with Different Hormone Dependencies / J.Koh et al. / p637~637
  • General Lecture 618.Serum Pregnancy-Associated α₂-Glycoprotein(α₂PAG)in Patients with Breast Cancer / K.Oshima et al. / p637~637
  • General Lecture 619.Not Received / /
  • General Lecture 620.Significance of the Lymphoid Infiltration in Tumors with Intratumoral Injection of N-CWS / J.Ichikawa et al. / p638~638
  • General Lecture 621.A Study of the Patients of Breast Cancer with Histologically Negative Axillary Lymphnodes (nO Breast Cancer Patients) / T.Asagoe et al. / p638~638
  • General Lecture 622.Ultrasonographic Diagnosis for Early Breast Cancer(Tl) / H.Imamoto et al. / p639~639
  • General Lecture 623.Results of Surgical-adjuvant Immunochemotherapy for Breast Cancer with Special Reference to Immunological Parameters / M.Fujimoto et al. / p639~639
  • General Lecture 624.Preoperative Immunotherapy for Breast Cancer--The Effect of Immunostimulant,Levamisole(LMS)and Krestin(PSK),on the Regional Lymphnode / K.Hoshino et al. / p640~640
  • General Lecture 625.Efficacy of Preoperative Chemotherapy for Primary Breast Cancer / Y.Hara et al. / p640~640
  • General Lecture 626.Effect of Selective Anticancer Agent(KM2210)on Recurrent Breast Cancer / Z.Yamazaki et al. / p641~641
  • General Lecture 627.New Trials of Chemotherapy Utilizing Vindesine Sulfate(VDS)in Refractory Breast Cancer / H.Yamamoto et al. / p641~641
  • General Lecture 628.The Effect of Administering Lentinan to Patients with Advanced or Recurrent Breast Cancer Following Bilateral Oophorectomy and Adrenectomy / A.Kosaka et al. / p642~642
  • General Lecture 629.Clinical Investigation with the use of Continuous Local Microinfusion of Peplomycin in Treatment of Local Recurrence of Breast and Tracheal Cancer / T.Tatsumura et al. / p642~642
  • General Lecture 630.Effects of Multiple Combination Chemotherapy with Vincristine,Endoxan Methotrexate,5-Fluorouracil,Adriamycin and Prednisolone"VEMFAH"for Advanced Breast Cancer / A.Hoshino et al. / p643~643
  • General Lecture 631.The Change of Cell Mediated Immunity under the Postoperative Chemotherapy(MAF)against Gastric Cancer--Especially the Changes of Purine Nucleoside Phosphorylase Activity in the Peripheral Lymphocyte / E.Sudo et al. / p643~643
  • General Lecture 632.Screening for Anticancer Drug Sensitivity of Bone and Soft-part Tumors--Neutral Red Dye-Uptake Method / T.Nakata et al. / p644~644
  • General Lecture 633.Not Received / /
  • General Lecture 634.The Proportions of T-cell Subsets in Peripheral Blood and at Tumor Margin Defined by Monoclonal Antibodies in Patients with Cervical Cancer / S.Yamagiwa et al. / p644~644
  • General Lecture 635.Serum Mucoprotein of Cervical Cancer Patients / K.Yamamoto et al. / p645~645
  • General Lecture 636.The Relation of Histologic Effect and Tumor Vascularity after Chemotherapy on DMBA-induced Rat Ovarian Cancer / T.Oda et al. / p645~645
  • General Lecture 637.Cases of Long Term Life After Recurrence of Gynecologic Cancers / M.Saito / p646~646
  • General Lecture 638.Study on Cellular Immune Reactivities in the Patients with Advanced Cervical Cancer after Treatments Part 4 :Changes in Cellular Immune Reactivities and Prognosis in the Group of Patients Treated with Immunotherapy / K.Hasegawa et al. / p646~646
  • General Lecture 639.Effect of Immunotherapy Using OK432 for Malignant Ovarian Tumor / T.Kano et al. / p647~647
  • General Lecture 640.Maintenance Chemoimmunotherapy for Patients with Uterine Cervical Cancer--Case Studies in Which OK432 is Combined with Other Chemotherapeutic Agents for Long-term Therapy / H.Taniguchi et al. / p647~647
  • General Lecture 641.Significance of Serum IAP Levels in Gynecological Malignancies / T.Muroya et al. / p648~648
  • General Lecture 642.Cellular Immunity of the Cervical Cancer Patient--The Significance of Blastgenesis of the Lymphocytes from the Peripheral Blood and the Regional Lymphonode / N.Kunimi et al. / p648~648
  • General Lecture 643.Ovarian Immature Teratoma with Raised Serum AFP
  • Clinical Course and Immunohistology of the Two Cases / T.Ihara et al. / p649~649
  • General Lecture 644.Anticoagulant and Antifibrinolytic Treatment in Ovarian Cancer Patients / J. Chen et al. / p649~649
  • General Lecture 645.Combination Chemotherapy of Disseminated Uterine Cervical Carcinoma with Pepleomycin(PEP)and Mitomycin C(MMC) / M.Suzuki et al. / p650~650
  • General Lecture 646.The Local Therapy of Early Cervical Cancer with the Suppository of 5-Fluorouracil / A.Kimura et al. / p650~650
  • General Lecture 647.Not Received / /
  • General Lecture 648.Studies on Changes of NK Activities in Patients with Cancer of the Ovary / Y.Kikuchi et al. / p651~651
  • General Lecture 649.Effect of Domperidone on Nausea and Vomiting Induced by Anti Cancer Agents / H.Katabuchi et al. / p651~651

「国立国会図書館デジタルコレクション(雑誌)」より

この本の情報

書名 日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology
著作者等 日本癌治療学会
書名ヨミ ニホン ガン チリョウ ガッカイシ = The journal of Japan Society of Clinical Oncology
書名別名 The journal of Japan Society for Cancer Therapy

日本癌治療学会学術集会educational book

日本癌治療学会学術集会プログラム号

日本癌治療学会学術集会抄録号

The journal of Japan Society of Clinical Oncology
巻冊次 18(2)
出版元 日本癌治療学会
刊行年月 1983-03
ページ数
大きさ 25-30cm
ISSN 00214671
NCID AN00187361
※クリックでCiNii Booksを表示
全国書誌番号
00018418
※クリックで国立国会図書館サーチを表示
言語 英語
日本語
出版国 日本
この本を: 
このエントリーをはてなブックマークに追加

Yahoo!ブックマークに登録
この記事をクリップ!
Clip to Evernote
このページを印刷

外部サイトで検索

この本と繋がる本を検索

ウィキペディアから連想